Gene Symbol | Gene ID | Gene Info |
---|---|---|
Nr1i2
|
ENSMUSG00000022809.4 | nuclear receptor subfamily 1, group I, member 2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr16_38295281_38295432 | Nr1i2 | 532 | 0.709045 | 0.25 | 5.7e-02 | Click! |
chr16_38294151_38294355 | Nr1i2 | 571 | 0.685247 | 0.25 | 5.8e-02 | Click! |
chr16_38295581_38295732 | Nr1i2 | 832 | 0.529950 | 0.21 | 1.2e-01 | Click! |
chr16_38288059_38288210 | Nr1i2 | 6690 | 0.150937 | 0.17 | 1.8e-01 | Click! |
chr16_38288700_38288883 | Nr1i2 | 6033 | 0.153480 | 0.17 | 1.9e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr6_55336550_55338274 | 11.79 |
Aqp1 |
aquaporin 1 |
980 |
0.5 |
chr1_51288641_51290950 | 10.57 |
Cavin2 |
caveolae associated 2 |
669 |
0.72 |
chr3_129331827_129332986 | 7.70 |
Enpep |
glutamyl aminopeptidase |
142 |
0.95 |
chrX_157701658_157702782 | 7.03 |
Smpx |
small muscle protein, X-linked |
378 |
0.83 |
chr11_75165245_75169157 | 6.57 |
Hic1 |
hypermethylated in cancer 1 |
945 |
0.35 |
chr18_41860653_41861741 | 6.49 |
Gm50410 |
predicted gene, 50410 |
13637 |
0.22 |
chr14_101886945_101887764 | 6.39 |
Lmo7 |
LIM domain only 7 |
3235 |
0.35 |
chr1_134802830_134803774 | 6.03 |
Ppp1r12b |
protein phosphatase 1, regulatory subunit 12B |
549 |
0.61 |
chr9_105520039_105521535 | 5.95 |
Atp2c1 |
ATPase, Ca++-sequestering |
360 |
0.86 |
chr14_63244119_63245953 | 5.92 |
Gata4 |
GATA binding protein 4 |
212 |
0.93 |
chr11_5897192_5898699 | 5.90 |
Myl7 |
myosin, light polypeptide 7, regulatory |
837 |
0.46 |
chr1_34120973_34122005 | 5.84 |
Dst |
dystonin |
239 |
0.92 |
chr17_26838158_26839992 | 5.77 |
Nkx2-5 |
NK2 homeobox 5 |
2490 |
0.17 |
chr2_163395773_163396078 | 5.72 |
Jph2 |
junctophilin 2 |
2024 |
0.24 |
chr6_48676062_48676718 | 5.68 |
Gimap9 |
GTPase, IMAP family member 9 |
261 |
0.79 |
chr5_53469318_53470522 | 5.65 |
Rbpj |
recombination signal binding protein for immunoglobulin kappa J region |
3768 |
0.25 |
chr1_90842678_90843968 | 5.59 |
Col6a3 |
collagen, type VI, alpha 3 |
605 |
0.7 |
chr1_193152798_193154089 | 5.57 |
Irf6 |
interferon regulatory factor 6 |
289 |
0.85 |
chr10_5287995_5289689 | 5.54 |
Gm23573 |
predicted gene, 23573 |
68331 |
0.12 |
chr7_141009744_141010714 | 5.52 |
Ifitm3 |
interferon induced transmembrane protein 3 |
541 |
0.54 |
chr5_134745620_134746234 | 5.50 |
Gm30003 |
predicted gene, 30003 |
1115 |
0.35 |
chr8_94976904_94978618 | 5.49 |
Adgrg1 |
adhesion G protein-coupled receptor G1 |
652 |
0.59 |
chr2_91119045_91119896 | 5.45 |
Mybpc3 |
myosin binding protein C, cardiac |
1326 |
0.3 |
chr2_102899434_102899944 | 5.42 |
Cd44 |
CD44 antigen |
1657 |
0.34 |
chr10_127749619_127751660 | 5.38 |
Gpr182 |
G protein-coupled receptor 182 |
1093 |
0.28 |
chr7_127992791_127993997 | 5.36 |
Gm45205 |
predicted gene 45205 |
125 |
0.49 |
chr2_180388160_180389480 | 5.33 |
Mir1a-1 |
microRNA 1a-1 |
228 |
0.89 |
chr14_63268302_63270010 | 5.33 |
Gata4 |
GATA binding protein 4 |
1968 |
0.31 |
chr7_48847211_48847926 | 5.22 |
Csrp3 |
cysteine and glycine-rich protein 3 |
465 |
0.76 |
chr2_19660039_19660459 | 5.16 |
Otud1 |
OTU domain containing 1 |
2497 |
0.19 |
chrX_106839224_106840351 | 5.15 |
Rtl3 |
retrotransposon Gag like 3 |
857 |
0.6 |
chr12_117657998_117660727 | 5.11 |
Rapgef5 |
Rap guanine nucleotide exchange factor (GEF) 5 |
1328 |
0.51 |
chr1_135801315_135801656 | 5.07 |
Tnni1 |
troponin I, skeletal, slow 1 |
1652 |
0.29 |
chr3_51377993_51378402 | 5.04 |
Gm5103 |
predicted gene 5103 |
121 |
0.93 |
chr17_48431455_48432112 | 4.95 |
Apobec2 |
apolipoprotein B mRNA editing enzyme, catalytic polypeptide 2 |
835 |
0.47 |
chr6_91795276_91796520 | 4.93 |
Grip2 |
glutamate receptor interacting protein 2 |
346 |
0.87 |
chr2_76980555_76980961 | 4.87 |
Ttn |
titin |
576 |
0.81 |
chr2_173024069_173026002 | 4.84 |
Rbm38 |
RNA binding motif protein 38 |
1985 |
0.21 |
chr9_50752994_50754649 | 4.84 |
Cryab |
crystallin, alpha B |
574 |
0.54 |
chr16_43363328_43363642 | 4.84 |
Zbtb20 |
zinc finger and BTB domain containing 20 |
21 |
0.7 |
chr17_28007198_28009699 | 4.81 |
Anks1 |
ankyrin repeat and SAM domain containing 1 |
1103 |
0.37 |
chrX_48146526_48147857 | 4.74 |
Sash3 |
SAM and SH3 domain containing 3 |
755 |
0.65 |
chr11_5505783_5506171 | 4.71 |
Gm11963 |
predicted gene 11963 |
7137 |
0.14 |
chr2_155612818_155614078 | 4.70 |
Myh7b |
myosin, heavy chain 7B, cardiac muscle, beta |
2236 |
0.14 |
chr2_114055154_114055663 | 4.69 |
C130080G10Rik |
RIKEN cDNA C130080G10 gene |
161 |
0.93 |
chr7_141338447_141340687 | 4.68 |
Eps8l2 |
EPS8-like 2 |
561 |
0.53 |
chr10_7472799_7473709 | 4.67 |
Ulbp1 |
UL16 binding protein 1 |
87 |
0.97 |
chr2_155611238_155612364 | 4.59 |
Myh7b |
myosin, heavy chain 7B, cardiac muscle, beta |
589 |
0.53 |
chr9_72448745_72450029 | 4.57 |
Gm27231 |
predicted gene 27231 |
7608 |
0.08 |
chr14_31166307_31168596 | 4.54 |
Stab1 |
stabilin 1 |
1144 |
0.34 |
chr3_123033789_123034940 | 4.50 |
Myoz2 |
myozenin 2 |
480 |
0.73 |
chr3_79885722_79887545 | 4.50 |
Gm36569 |
predicted gene, 36569 |
173 |
0.83 |
chr17_12766020_12767485 | 4.49 |
Igf2r |
insulin-like growth factor 2 receptor |
2912 |
0.17 |
chr3_10206707_10207467 | 4.45 |
Fabp4 |
fatty acid binding protein 4, adipocyte |
1471 |
0.24 |
chr2_84475523_84476677 | 4.42 |
Tfpi |
tissue factor pathway inhibitor |
648 |
0.7 |
chr6_97353472_97354280 | 4.39 |
Frmd4b |
FERM domain containing 4B |
301 |
0.93 |
chr6_5255342_5256653 | 4.38 |
Pon3 |
paraoxonase 3 |
217 |
0.93 |
chr7_128205575_128206445 | 4.35 |
Cox6a2 |
cytochrome c oxidase subunit 6A2 |
377 |
0.67 |
chr17_43360343_43362046 | 4.35 |
Adgrf5 |
adhesion G protein-coupled receptor F5 |
743 |
0.75 |
chr16_95456632_95459094 | 4.32 |
Erg |
ETS transcription factor |
1382 |
0.55 |
chr6_55338294_55340060 | 4.31 |
Aqp1 |
aquaporin 1 |
2745 |
0.22 |
chr12_34713492_34714861 | 4.20 |
Gm47357 |
predicted gene, 47357 |
85538 |
0.09 |
chr3_138067510_138069146 | 4.18 |
Gm5105 |
predicted gene 5105 |
940 |
0.46 |
chr18_32818058_32818628 | 4.17 |
Tslp |
thymic stromal lymphopoietin |
1483 |
0.34 |
chr15_77021062_77022444 | 4.13 |
Mb |
myoglobin |
210 |
0.89 |
chr3_60408400_60409132 | 4.12 |
Mbnl1 |
muscleblind like splicing factor 1 |
64064 |
0.12 |
chr11_77800451_77802048 | 4.12 |
Myo18a |
myosin XVIIIA |
49 |
0.97 |
chr8_120264530_120265775 | 4.12 |
Gse1 |
genetic suppressor element 1, coiled-coil protein |
36696 |
0.14 |
chr14_66279066_66281333 | 4.09 |
Ptk2b |
PTK2 protein tyrosine kinase 2 beta |
783 |
0.61 |
chr4_130173825_130175545 | 4.06 |
Tinagl1 |
tubulointerstitial nephritis antigen-like 1 |
6 |
0.97 |
chr5_21543417_21545108 | 4.03 |
Lrrc17 |
leucine rich repeat containing 17 |
699 |
0.68 |
chr15_101293230_101294713 | 4.02 |
Smim41 |
small integral membrane protein 41 |
739 |
0.47 |
chr10_5595083_5595567 | 4.00 |
Myct1 |
myc target 1 |
1550 |
0.45 |
chr10_39612918_39613668 | 4.00 |
Traf3ip2 |
TRAF3 interacting protein 2 |
359 |
0.48 |
chr17_34998907_34999597 | 3.97 |
Vars |
valyl-tRNA synthetase |
1735 |
0.11 |
chr11_70614847_70615992 | 3.97 |
Chrne |
cholinergic receptor, nicotinic, epsilon polypeptide |
254 |
0.58 |
chr17_75435976_75437284 | 3.96 |
Rasgrp3 |
RAS, guanyl releasing protein 3 |
704 |
0.77 |
chr6_112273463_112275203 | 3.95 |
Lmcd1 |
LIM and cysteine-rich domains 1 |
575 |
0.71 |
chr3_84189998_84191469 | 3.93 |
Trim2 |
tripartite motif-containing 2 |
210 |
0.94 |
chr7_19821864_19823009 | 3.91 |
Bcl3 |
B cell leukemia/lymphoma 3 |
279 |
0.77 |
chr2_32081622_32082932 | 3.91 |
Fam78a |
family with sequence similarity 78, member A |
1506 |
0.26 |
chr16_38364563_38365451 | 3.91 |
Popdc2 |
popeye domain containing 2 |
2762 |
0.17 |
chr11_101771824_101772990 | 3.90 |
Etv4 |
ets variant 4 |
226 |
0.91 |
chr6_24597837_24598262 | 3.90 |
Lmod2 |
leiomodin 2 (cardiac) |
287 |
0.88 |
chr5_33217001_33218450 | 3.89 |
Spon2 |
spondin 2, extracellular matrix protein |
460 |
0.79 |
chr7_138907945_138908096 | 3.87 |
Bnip3 |
BCL2/adenovirus E1B interacting protein 3 |
1459 |
0.27 |
chr1_125431760_125432298 | 3.86 |
Actr3 |
ARP3 actin-related protein 3 |
2617 |
0.33 |
chr1_125676834_125678312 | 3.84 |
Gpr39 |
G protein-coupled receptor 39 |
578 |
0.8 |
chr11_83849571_83850989 | 3.82 |
Hnf1b |
HNF1 homeobox B |
217 |
0.83 |
chr8_47994470_47995597 | 3.82 |
Wwc2 |
WW, C2 and coiled-coil domain containing 2 |
4109 |
0.22 |
chr11_94498570_94500249 | 3.78 |
Epn3 |
epsin 3 |
289 |
0.85 |
chr7_101394207_101396000 | 3.77 |
Arap1 |
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1 |
448 |
0.73 |
chr2_76982792_76983214 | 3.76 |
Ttn |
titin |
456 |
0.86 |
chr5_35727822_35729089 | 3.76 |
Sh3tc1 |
SH3 domain and tetratricopeptide repeats 1 |
557 |
0.73 |
chr6_135362982_135365483 | 3.75 |
Emp1 |
epithelial membrane protein 1 |
1164 |
0.42 |
chrX_133980931_133982115 | 3.73 |
Sytl4 |
synaptotagmin-like 4 |
260 |
0.92 |
chr18_11049995_11051717 | 3.73 |
Gata6os |
GATA binding protein 6, opposite strand |
631 |
0.64 |
chr5_102724663_102726037 | 3.72 |
Arhgap24 |
Rho GTPase activating protein 24 |
377 |
0.93 |
chr5_143625482_143626083 | 3.72 |
Cyth3 |
cytohesin 3 |
3248 |
0.24 |
chr2_148441004_148443557 | 3.72 |
Cd93 |
CD93 antigen |
1283 |
0.41 |
chr1_135324343_135325907 | 3.71 |
Lmod1 |
leiomodin 1 (smooth muscle) |
318 |
0.83 |
chr19_5842574_5845856 | 3.71 |
Neat1 |
nuclear paraspeckle assembly transcript 1 (non-protein coding) |
1044 |
0.25 |
chr9_107298004_107299417 | 3.71 |
Cish |
cytokine inducible SH2-containing protein |
445 |
0.63 |
chr2_32080366_32081236 | 3.71 |
Fam78a |
family with sequence similarity 78, member A |
1449 |
0.27 |
chr7_75612178_75613652 | 3.71 |
Akap13 |
A kinase (PRKA) anchor protein 13 |
631 |
0.75 |
chr16_57551520_57552150 | 3.69 |
Filip1l |
filamin A interacting protein 1-like |
2593 |
0.35 |
chr7_89406807_89407562 | 3.66 |
Fzd4 |
frizzled class receptor 4 |
2829 |
0.19 |
chr16_21818680_21818960 | 3.66 |
Map3k13 |
mitogen-activated protein kinase kinase kinase 13 |
7122 |
0.12 |
chr18_3509793_3510792 | 3.66 |
Bambi |
BMP and activin membrane-bound inhibitor |
2369 |
0.24 |
chr5_116421567_116422547 | 3.61 |
Hspb8 |
heat shock protein 8 |
807 |
0.51 |
chr14_36918744_36919600 | 3.61 |
Ccser2 |
coiled-coil serine rich 2 |
161 |
0.97 |
chr7_142576289_142578620 | 3.60 |
H19 |
H19, imprinted maternally expressed transcript |
68 |
0.78 |
chr10_80584595_80587584 | 3.59 |
Abhd17a |
abhydrolase domain containing 17A |
535 |
0.53 |
chr1_23321078_23322043 | 3.59 |
Gm20954 |
predicted gene, 20954 |
25039 |
0.11 |
chr15_99032182_99033105 | 3.59 |
Tuba1c |
tubulin, alpha 1C |
2322 |
0.15 |
chr11_88998963_89000826 | 3.58 |
Trim25 |
tripartite motif-containing 25 |
518 |
0.65 |
chr14_31209518_31210345 | 3.57 |
Tnnc1 |
troponin C, cardiac/slow skeletal |
1599 |
0.22 |
chr15_50362044_50362277 | 3.56 |
Gm49198 |
predicted gene, 49198 |
75262 |
0.13 |
chr6_42352223_42352654 | 3.54 |
Zyx |
zyxin |
1040 |
0.28 |
chr3_138064815_138065971 | 3.54 |
1110002E22Rik |
RIKEN cDNA 1110002E22 gene |
341 |
0.81 |
chr17_71019478_71020561 | 3.54 |
Myom1 |
myomesin 1 |
428 |
0.76 |
chr2_7080065_7080255 | 3.51 |
Celf2 |
CUGBP, Elav-like family member 2 |
1047 |
0.66 |
chr14_26440622_26440948 | 3.50 |
Slmap |
sarcolemma associated protein |
1564 |
0.34 |
chr18_11060814_11061287 | 3.49 |
Gata6 |
GATA binding protein 6 |
2003 |
0.37 |
chr3_151439095_151439963 | 3.49 |
Adgrl4 |
adhesion G protein-coupled receptor L4 |
191 |
0.97 |
chr6_4338194_4338657 | 3.49 |
Gm8602 |
predicted gene 8602 |
20603 |
0.14 |
chr17_27056279_27056743 | 3.48 |
Itpr3 |
inositol 1,4,5-triphosphate receptor 3 |
793 |
0.44 |
chr3_138000878_138001680 | 3.48 |
Gm19708 |
predicted gene, 19708 |
340 |
0.84 |
chr16_4520955_4521652 | 3.48 |
Srl |
sarcalumenin |
1760 |
0.3 |
chr5_32137776_32137927 | 3.48 |
Fosl2 |
fos-like antigen 2 |
1678 |
0.31 |
chr6_24598951_24599156 | 3.47 |
Lmod2 |
leiomodin 2 (cardiac) |
1291 |
0.38 |
chr12_5191684_5192484 | 3.46 |
Gm48532 |
predicted gene, 48532 |
43880 |
0.16 |
chr4_46040988_46042013 | 3.45 |
Tmod1 |
tropomodulin 1 |
2291 |
0.3 |
chr7_19082814_19086200 | 3.45 |
Dmpk |
dystrophia myotonica-protein kinase |
203 |
0.83 |
chr15_96507304_96507605 | 3.44 |
Gm41392 |
predicted gene, 41392 |
9552 |
0.22 |
chr7_100926314_100930096 | 3.43 |
Arhgef17 |
Rho guanine nucleotide exchange factor (GEF) 17 |
3902 |
0.17 |
chr15_85645713_85647012 | 3.40 |
Gm49539 |
predicted gene, 49539 |
279 |
0.89 |
chr10_96370673_96371663 | 3.40 |
Gm48428 |
predicted gene, 48428 |
25344 |
0.16 |
chr7_45337299_45338455 | 3.39 |
Hrc |
histidine rich calcium binding protein |
2530 |
0.09 |
chr8_57324709_57326732 | 3.39 |
Hand2os1 |
Hand2, opposite strand 1 |
1487 |
0.3 |
chr2_79087179_79088090 | 3.39 |
Gm14469 |
predicted gene 14469 |
48900 |
0.14 |
chr12_102369060_102369808 | 3.38 |
Rin3 |
Ras and Rab interactor 3 |
14654 |
0.19 |
chr15_66967368_66967519 | 3.37 |
Ndrg1 |
N-myc downstream regulated gene 1 |
482 |
0.75 |
chr10_53339922_53340236 | 3.37 |
Pln |
phospholamban |
2374 |
0.19 |
chr19_5724785_5726881 | 3.37 |
Ehbp1l1 |
EH domain binding protein 1-like 1 |
437 |
0.54 |
chr11_120950276_120950971 | 3.36 |
Slc16a3 |
solute carrier family 16 (monocarboxylic acid transporters), member 3 |
65 |
0.95 |
chr12_35532487_35532918 | 3.34 |
Gm48236 |
predicted gene, 48236 |
1719 |
0.29 |
chr1_112456050_112456433 | 3.33 |
Gm22331 |
predicted gene, 22331 |
11670 |
0.27 |
chr17_24643558_24645911 | 3.33 |
Slc9a3r2 |
solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 2 |
223 |
0.82 |
chr5_119830922_119832010 | 3.31 |
Gm43050 |
predicted gene 43050 |
325 |
0.82 |
chrX_133908388_133909247 | 3.31 |
Srpx2 |
sushi-repeat-containing protein, X-linked 2 |
369 |
0.84 |
chr2_91964507_91965860 | 3.31 |
Dgkz |
diacylglycerol kinase zeta |
404 |
0.78 |
chr12_57542139_57543972 | 3.31 |
Foxa1 |
forkhead box A1 |
3066 |
0.2 |
chr5_143625078_143625267 | 3.30 |
Cyth3 |
cytohesin 3 |
2638 |
0.27 |
chr3_79887847_79889192 | 3.30 |
Gm36569 |
predicted gene, 36569 |
1713 |
0.31 |
chr2_91096772_91098746 | 3.29 |
Spi1 |
spleen focus forming virus (SFFV) proviral integration oncogene |
979 |
0.4 |
chr11_32296600_32297646 | 3.29 |
Hba-a2 |
hemoglobin alpha, adult chain 2 |
495 |
0.66 |
chr6_29434692_29436459 | 3.29 |
Flnc |
filamin C, gamma |
2299 |
0.16 |
chr10_109921017_109921811 | 3.28 |
Nav3 |
neuron navigator 3 |
17391 |
0.27 |
chr7_116197315_116198543 | 3.27 |
Plekha7 |
pleckstrin homology domain containing, family A member 7 |
632 |
0.75 |
chr3_70806803_70807039 | 3.26 |
Gm10780 |
predicted gene 10780 |
117829 |
0.07 |
chr5_74197172_74198949 | 3.26 |
Rasl11b |
RAS-like, family 11, member B |
169 |
0.94 |
chr9_116873425_116874050 | 3.25 |
Rbms3 |
RNA binding motif, single stranded interacting protein |
50918 |
0.18 |
chr1_184675496_184676152 | 3.24 |
Gm38358 |
predicted gene, 38358 |
19210 |
0.14 |
chr15_102102931_102104191 | 3.24 |
Tns2 |
tensin 2 |
573 |
0.62 |
chr11_57830920_57832176 | 3.24 |
Hand1 |
heart and neural crest derivatives expressed 1 |
599 |
0.69 |
chr6_56901300_56901698 | 3.24 |
Nt5c3 |
5'-nucleotidase, cytosolic III |
384 |
0.8 |
chr13_90359638_90360333 | 3.22 |
Gm37708 |
predicted gene, 37708 |
26572 |
0.21 |
chr6_141250969_141251472 | 3.22 |
Gm28523 |
predicted gene 28523 |
1211 |
0.38 |
chr6_49039762_49040340 | 3.22 |
Gpnmb |
glycoprotein (transmembrane) nmb |
3374 |
0.13 |
chr12_103336858_103338251 | 3.20 |
Gm15523 |
predicted gene 15523 |
648 |
0.43 |
chr7_100492685_100494805 | 3.19 |
Ucp2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
50 |
0.95 |
chr3_102086617_102087454 | 3.19 |
Casq2 |
calsequestrin 2 |
396 |
0.81 |
chr7_101377838_101379825 | 3.17 |
Arap1 |
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1 |
462 |
0.71 |
chr5_119685576_119687800 | 3.16 |
Tbx3os2 |
T-box 3, opposite strand 2 |
4530 |
0.17 |
chr16_55820581_55820972 | 3.15 |
Nfkbiz |
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, zeta |
1362 |
0.42 |
chr14_114842221_114842586 | 3.15 |
4930524C18Rik |
RIKEN cDNA 4930524C18 gene |
10438 |
0.18 |
chr1_172501767_172503923 | 3.15 |
Tagln2 |
transgelin 2 |
1593 |
0.22 |
chr10_80347716_80349512 | 3.15 |
Adamtsl5 |
ADAMTS-like 5 |
202 |
0.82 |
chr18_35847749_35850271 | 3.14 |
Cxxc5 |
CXXC finger 5 |
5677 |
0.11 |
chr17_3397051_3398448 | 3.13 |
Tiam2 |
T cell lymphoma invasion and metastasis 2 |
519 |
0.8 |
chr11_97148632_97149772 | 3.13 |
Tbkbp1 |
TBK1 binding protein 1 |
510 |
0.61 |
chr3_14889110_14890285 | 3.13 |
Car2 |
carbonic anhydrase 2 |
3058 |
0.25 |
chr13_89540278_89541317 | 3.12 |
Hapln1 |
hyaluronan and proteoglycan link protein 1 |
1001 |
0.64 |
chr3_20153107_20153379 | 3.12 |
Gyg |
glycogenin |
1826 |
0.36 |
chr7_48845512_48846051 | 3.12 |
Csrp3 |
cysteine and glycine-rich protein 3 |
562 |
0.7 |
chr9_44087472_44088439 | 3.12 |
Usp2 |
ubiquitin specific peptidase 2 |
765 |
0.37 |
chr11_51648294_51649457 | 3.11 |
N4bp3 |
NEDD4 binding protein 3 |
1945 |
0.2 |
chrX_103448739_103449535 | 3.11 |
Tsix |
X (inactive)-specific transcript, opposite strand |
1415 |
0.24 |
chr6_34862829_34863673 | 3.10 |
Tmem140 |
transmembrane protein 140 |
11 |
0.96 |
chr4_154926952_154928851 | 3.09 |
Tnfrsf14 |
tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator) |
176 |
0.92 |
chr14_101842332_101842898 | 3.08 |
Lmo7 |
LIM domain only 7 |
1796 |
0.46 |
chr3_51378444_51378901 | 3.08 |
Gm5103 |
predicted gene 5103 |
596 |
0.57 |
chr5_91402281_91403314 | 3.07 |
Btc |
betacellulin, epidermal growth factor family member |
25 |
0.99 |
chr10_58394296_58394848 | 3.07 |
Lims1 |
LIM and senescent cell antigen-like domains 1 |
184 |
0.95 |
chr14_101888217_101888439 | 3.06 |
Lmo7 |
LIM domain only 7 |
4209 |
0.32 |
chr9_50751156_50752468 | 3.06 |
Cryab |
crystallin, alpha B |
65 |
0.86 |
chr17_78734767_78735199 | 3.05 |
Strn |
striatin, calmodulin binding protein |
2213 |
0.24 |
chr1_126603873_126604673 | 3.05 |
Nckap5 |
NCK-associated protein 5 |
111346 |
0.07 |
chr12_40198308_40199492 | 3.05 |
Gm17056 |
predicted gene 17056 |
244 |
0.64 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.4 | 16.2 | GO:0048769 | sarcomerogenesis(GO:0048769) |
4.1 | 12.4 | GO:0051891 | positive regulation of cardioblast differentiation(GO:0051891) |
3.9 | 11.7 | GO:0003289 | atrial septum primum morphogenesis(GO:0003289) |
3.8 | 7.7 | GO:0035995 | detection of muscle stretch(GO:0035995) |
3.3 | 9.9 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
3.0 | 9.1 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
3.0 | 12.0 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
2.9 | 8.6 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) |
2.8 | 11.4 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
2.6 | 13.1 | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction(GO:0086064) |
2.5 | 7.4 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
2.2 | 10.9 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
2.1 | 12.6 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
2.0 | 6.1 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
1.9 | 5.8 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
1.9 | 1.9 | GO:0071688 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
1.8 | 18.4 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
1.8 | 7.2 | GO:0003175 | tricuspid valve development(GO:0003175) |
1.8 | 5.3 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
1.7 | 5.1 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
1.6 | 6.4 | GO:0097460 | ferrous iron import into cell(GO:0097460) |
1.6 | 1.6 | GO:0042520 | positive regulation of tyrosine phosphorylation of Stat4 protein(GO:0042520) |
1.6 | 9.5 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
1.6 | 6.2 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
1.5 | 7.7 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
1.5 | 3.1 | GO:0031034 | myosin filament assembly(GO:0031034) |
1.5 | 4.5 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
1.4 | 1.4 | GO:2000668 | dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
1.4 | 7.1 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
1.4 | 5.6 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
1.4 | 1.4 | GO:2001197 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
1.4 | 4.1 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
1.3 | 1.3 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
1.3 | 12.1 | GO:0098911 | regulation of ventricular cardiac muscle cell action potential(GO:0098911) |
1.3 | 4.0 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
1.3 | 1.3 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
1.3 | 2.6 | GO:0061325 | cell proliferation involved in outflow tract morphogenesis(GO:0061325) |
1.3 | 2.6 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
1.3 | 3.8 | GO:0035483 | gastric emptying(GO:0035483) |
1.3 | 5.1 | GO:0048014 | Tie signaling pathway(GO:0048014) |
1.3 | 2.5 | GO:0003228 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
1.3 | 3.8 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
1.3 | 6.3 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
1.2 | 3.7 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) |
1.2 | 5.0 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
1.2 | 5.0 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
1.2 | 3.7 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
1.2 | 4.9 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
1.2 | 3.7 | GO:0072125 | negative regulation of glomerular mesangial cell proliferation(GO:0072125) negative regulation of glomerulus development(GO:0090194) |
1.2 | 2.4 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
1.2 | 4.9 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
1.2 | 2.4 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
1.2 | 3.6 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
1.2 | 4.8 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
1.2 | 1.2 | GO:0070103 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) |
1.2 | 4.8 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
1.2 | 3.5 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
1.2 | 3.5 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
1.2 | 4.6 | GO:0099624 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
1.2 | 8.1 | GO:0042693 | muscle cell fate commitment(GO:0042693) |
1.1 | 1.1 | GO:1904504 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
1.1 | 10.3 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
1.1 | 3.4 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
1.1 | 6.8 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
1.1 | 1.1 | GO:0097360 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
1.1 | 2.3 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
1.1 | 3.4 | GO:0036023 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
1.1 | 2.3 | GO:0071415 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
1.1 | 3.3 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
1.1 | 3.3 | GO:0003104 | positive regulation of glomerular filtration(GO:0003104) |
1.1 | 7.8 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
1.1 | 6.6 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
1.1 | 3.3 | GO:0070836 | caveola assembly(GO:0070836) |
1.1 | 3.3 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
1.1 | 3.3 | GO:0021564 | vagus nerve development(GO:0021564) |
1.1 | 5.4 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
1.1 | 2.2 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
1.1 | 1.1 | GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
1.1 | 4.2 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
1.1 | 4.2 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
1.0 | 1.0 | GO:0043382 | positive regulation of memory T cell differentiation(GO:0043382) |
1.0 | 3.1 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
1.0 | 2.1 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
1.0 | 7.2 | GO:0007021 | tubulin complex assembly(GO:0007021) |
1.0 | 1.0 | GO:0033092 | positive regulation of immature T cell proliferation in thymus(GO:0033092) |
1.0 | 4.1 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
1.0 | 9.2 | GO:0008090 | retrograde axonal transport(GO:0008090) |
1.0 | 4.1 | GO:0032849 | positive regulation of cellular pH reduction(GO:0032849) |
1.0 | 4.1 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
1.0 | 3.1 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
1.0 | 3.0 | GO:0033505 | floor plate morphogenesis(GO:0033505) |
1.0 | 1.0 | GO:1902947 | regulation of tau-protein kinase activity(GO:1902947) |
1.0 | 3.0 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
1.0 | 4.9 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
1.0 | 3.9 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
1.0 | 3.9 | GO:0010881 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion(GO:0010881) |
1.0 | 2.9 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
1.0 | 1.0 | GO:1904192 | cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
1.0 | 3.8 | GO:0009838 | abscission(GO:0009838) |
0.9 | 2.8 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.9 | 2.8 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.9 | 6.6 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.9 | 1.9 | GO:0036166 | phenotypic switching(GO:0036166) |
0.9 | 4.6 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.9 | 7.4 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.9 | 1.9 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.9 | 2.8 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
0.9 | 1.8 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.9 | 5.5 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.9 | 0.9 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.9 | 4.6 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.9 | 2.7 | GO:0035284 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.9 | 1.8 | GO:0048371 | lateral mesoderm morphogenesis(GO:0048369) lateral mesoderm formation(GO:0048370) lateral mesodermal cell differentiation(GO:0048371) |
0.9 | 4.5 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.9 | 6.3 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.9 | 5.3 | GO:0015671 | oxygen transport(GO:0015671) |
0.9 | 2.7 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.9 | 6.2 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.9 | 2.7 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.9 | 2.6 | GO:2000449 | regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) |
0.9 | 1.7 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
0.9 | 0.9 | GO:0035482 | gastric motility(GO:0035482) |
0.9 | 2.6 | GO:0050904 | diapedesis(GO:0050904) |
0.9 | 0.9 | GO:1903598 | positive regulation of gap junction assembly(GO:1903598) |
0.9 | 1.7 | GO:0048320 | axial mesoderm formation(GO:0048320) |
0.9 | 4.3 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.9 | 0.9 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.9 | 2.6 | GO:0032512 | regulation of protein phosphatase type 2B activity(GO:0032512) negative regulation of protein phosphatase type 2B activity(GO:0032513) |
0.8 | 2.5 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.8 | 2.5 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.8 | 2.5 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.8 | 0.8 | GO:0002513 | tolerance induction to self antigen(GO:0002513) |
0.8 | 2.5 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.8 | 3.4 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
0.8 | 8.4 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) |
0.8 | 2.5 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.8 | 0.8 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.8 | 2.5 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.8 | 3.3 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.8 | 1.6 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.8 | 3.3 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.8 | 3.3 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.8 | 4.1 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.8 | 4.9 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.8 | 5.7 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.8 | 3.2 | GO:2000065 | negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
0.8 | 2.4 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
0.8 | 3.2 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.8 | 3.2 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.8 | 2.4 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.8 | 2.4 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.8 | 0.8 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.8 | 1.6 | GO:2001280 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.8 | 5.6 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.8 | 4.8 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.8 | 1.6 | GO:0006808 | regulation of nitrogen utilization(GO:0006808) |
0.8 | 4.7 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.8 | 3.9 | GO:1901341 | positive regulation of store-operated calcium channel activity(GO:1901341) |
0.8 | 0.8 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.8 | 1.5 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.8 | 1.5 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.8 | 1.5 | GO:0008228 | opsonization(GO:0008228) |
0.8 | 0.8 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.7 | 9.0 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.7 | 8.2 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.7 | 2.2 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.7 | 1.5 | GO:1905005 | regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905005) |
0.7 | 0.7 | GO:0031947 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) |
0.7 | 3.0 | GO:1903059 | regulation of protein lipidation(GO:1903059) |
0.7 | 2.2 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.7 | 2.2 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.7 | 1.5 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.7 | 1.5 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.7 | 8.8 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.7 | 1.5 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
0.7 | 13.2 | GO:0045214 | sarcomere organization(GO:0045214) |
0.7 | 2.2 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.7 | 2.2 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.7 | 3.6 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.7 | 4.3 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.7 | 1.4 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.7 | 0.7 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
0.7 | 1.4 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) |
0.7 | 2.1 | GO:0032264 | IMP salvage(GO:0032264) |
0.7 | 2.8 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.7 | 0.7 | GO:0003163 | sinoatrial node development(GO:0003163) |
0.7 | 3.5 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.7 | 2.1 | GO:0036394 | amylase secretion(GO:0036394) |
0.7 | 1.4 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.7 | 2.8 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.7 | 2.1 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.7 | 4.9 | GO:0060056 | mammary gland involution(GO:0060056) |
0.7 | 2.8 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.7 | 6.2 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.7 | 2.1 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.7 | 1.4 | GO:0042346 | positive regulation of NF-kappaB import into nucleus(GO:0042346) |
0.7 | 0.7 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.7 | 3.4 | GO:0032621 | interleukin-18 production(GO:0032621) |
0.7 | 11.6 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.7 | 2.0 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
0.7 | 2.0 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.7 | 4.1 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.7 | 4.7 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.7 | 2.0 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.7 | 1.3 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
0.7 | 2.7 | GO:0030091 | protein repair(GO:0030091) |
0.7 | 2.0 | GO:0061010 | gall bladder development(GO:0061010) |
0.7 | 2.0 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.7 | 1.3 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.7 | 2.7 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.7 | 0.7 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.7 | 1.3 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.7 | 1.3 | GO:0031033 | myosin filament organization(GO:0031033) |
0.7 | 1.3 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.7 | 2.0 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.7 | 1.3 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.7 | 3.3 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.7 | 1.3 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.7 | 7.2 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.7 | 2.6 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.7 | 2.0 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
0.7 | 1.3 | GO:1902965 | regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
0.6 | 1.3 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.6 | 2.6 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.6 | 3.9 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.6 | 2.6 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.6 | 0.6 | GO:0070487 | monocyte aggregation(GO:0070487) |
0.6 | 2.6 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
0.6 | 4.5 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
0.6 | 2.5 | GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
0.6 | 4.4 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.6 | 3.8 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.6 | 3.1 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.6 | 1.3 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.6 | 2.5 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.6 | 1.2 | GO:0002159 | desmosome assembly(GO:0002159) |
0.6 | 12.4 | GO:0003081 | regulation of systemic arterial blood pressure by renin-angiotensin(GO:0003081) |
0.6 | 5.6 | GO:0032060 | bleb assembly(GO:0032060) |
0.6 | 1.2 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.6 | 1.8 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.6 | 0.6 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.6 | 0.6 | GO:2000407 | regulation of T cell extravasation(GO:2000407) |
0.6 | 1.8 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.6 | 1.2 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.6 | 12.7 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.6 | 4.8 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.6 | 1.8 | GO:0009732 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.6 | 1.2 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.6 | 4.2 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.6 | 1.2 | GO:0035983 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.6 | 1.8 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.6 | 2.4 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.6 | 1.8 | GO:0033029 | regulation of neutrophil apoptotic process(GO:0033029) |
0.6 | 5.4 | GO:0060421 | positive regulation of heart growth(GO:0060421) |
0.6 | 4.7 | GO:0002827 | positive regulation of T-helper 1 type immune response(GO:0002827) |
0.6 | 0.6 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
0.6 | 1.8 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.6 | 3.0 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.6 | 13.0 | GO:0048821 | erythrocyte development(GO:0048821) |
0.6 | 2.4 | GO:0045915 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.6 | 1.8 | GO:0018158 | protein oxidation(GO:0018158) |
0.6 | 1.2 | GO:0032829 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) |
0.6 | 4.7 | GO:0097286 | iron ion import(GO:0097286) |
0.6 | 0.6 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.6 | 0.6 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.6 | 1.7 | GO:0048143 | astrocyte activation(GO:0048143) |
0.6 | 2.3 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.6 | 7.5 | GO:0014850 | response to muscle activity(GO:0014850) |
0.6 | 3.5 | GO:0060613 | fat pad development(GO:0060613) |
0.6 | 1.7 | GO:1905206 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
0.6 | 2.9 | GO:0046618 | drug export(GO:0046618) |
0.6 | 1.1 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.6 | 2.9 | GO:1903224 | regulation of endodermal cell differentiation(GO:1903224) |
0.6 | 0.6 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.6 | 2.8 | GO:0045624 | positive regulation of T-helper cell differentiation(GO:0045624) |
0.6 | 1.1 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.6 | 5.7 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.6 | 1.7 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
0.6 | 2.3 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.6 | 1.1 | GO:0043312 | neutrophil mediated immunity(GO:0002446) neutrophil degranulation(GO:0043312) |
0.6 | 3.3 | GO:0060979 | vasculogenesis involved in coronary vascular morphogenesis(GO:0060979) |
0.6 | 1.7 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.6 | 2.2 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.6 | 0.6 | GO:0043622 | cortical microtubule organization(GO:0043622) |
0.6 | 3.9 | GO:0014820 | tonic smooth muscle contraction(GO:0014820) |
0.6 | 1.7 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.5 | 1.6 | GO:0002554 | serotonin secretion by platelet(GO:0002554) |
0.5 | 2.7 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.5 | 0.5 | GO:0090270 | fibroblast growth factor production(GO:0090269) regulation of fibroblast growth factor production(GO:0090270) |
0.5 | 6.6 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.5 | 0.5 | GO:0061196 | fungiform papilla development(GO:0061196) |
0.5 | 1.6 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.5 | 2.2 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.5 | 2.7 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.5 | 1.1 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
0.5 | 0.5 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.5 | 1.6 | GO:0060099 | regulation of phagocytosis, engulfment(GO:0060099) |
0.5 | 0.5 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
0.5 | 1.1 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.5 | 1.1 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.5 | 1.6 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.5 | 0.5 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
0.5 | 1.1 | GO:0051466 | positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.5 | 3.7 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.5 | 2.7 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.5 | 1.1 | GO:0071351 | response to interleukin-18(GO:0070673) cellular response to interleukin-18(GO:0071351) |
0.5 | 2.1 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.5 | 3.2 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.5 | 2.1 | GO:0035590 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.5 | 0.5 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.5 | 3.2 | GO:2000400 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.5 | 0.5 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.5 | 1.6 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.5 | 1.5 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.5 | 2.6 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.5 | 5.6 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.5 | 0.5 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.5 | 1.5 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.5 | 0.5 | GO:0030239 | myofibril assembly(GO:0030239) |
0.5 | 1.0 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
0.5 | 0.5 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.5 | 2.5 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.5 | 2.5 | GO:0010744 | positive regulation of macrophage derived foam cell differentiation(GO:0010744) |
0.5 | 1.5 | GO:0015677 | copper ion import(GO:0015677) |
0.5 | 0.5 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
0.5 | 1.5 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.5 | 1.5 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.5 | 0.5 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
0.5 | 1.0 | GO:0034214 | protein hexamerization(GO:0034214) |
0.5 | 1.0 | GO:0042695 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.5 | 2.5 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.5 | 1.0 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.5 | 0.5 | GO:0060331 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.5 | 1.5 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.5 | 1.5 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.5 | 2.4 | GO:1903912 | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.5 | 2.4 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.5 | 4.9 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.5 | 0.5 | GO:1904994 | regulation of leukocyte adhesion to vascular endothelial cell(GO:1904994) |
0.5 | 1.0 | GO:0010224 | response to UV-B(GO:0010224) |
0.5 | 3.4 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.5 | 1.0 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.5 | 1.4 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
0.5 | 1.9 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.5 | 1.4 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.5 | 1.0 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.5 | 1.4 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.5 | 1.9 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.5 | 1.4 | GO:0009157 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
0.5 | 1.4 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
0.5 | 2.3 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.5 | 1.9 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.5 | 4.2 | GO:0070269 | pyroptosis(GO:0070269) |
0.5 | 1.9 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
0.5 | 0.9 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.5 | 0.5 | GO:0061045 | negative regulation of wound healing(GO:0061045) |
0.5 | 8.3 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.5 | 1.4 | GO:0072277 | metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
0.5 | 0.9 | GO:0061687 | detoxification of inorganic compound(GO:0061687) |
0.5 | 0.5 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.5 | 3.2 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.4 | 2.2 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.4 | 0.4 | GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
0.4 | 0.9 | GO:0015684 | ferrous iron transport(GO:0015684) |
0.4 | 1.8 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.4 | 10.2 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
0.4 | 0.4 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.4 | 5.3 | GO:2000257 | regulation of protein activation cascade(GO:2000257) |
0.4 | 1.3 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.4 | 9.2 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.4 | 1.3 | GO:0090467 | L-arginine import(GO:0043091) arginine import(GO:0090467) L-arginine transport(GO:1902023) |
0.4 | 3.0 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.4 | 3.9 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.4 | 1.7 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.4 | 4.8 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.4 | 0.9 | GO:0090324 | negative regulation of oxidative phosphorylation(GO:0090324) |
0.4 | 0.4 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.4 | 4.8 | GO:0070875 | positive regulation of glycogen metabolic process(GO:0070875) |
0.4 | 1.3 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.4 | 0.9 | GO:0002249 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
0.4 | 3.5 | GO:0044247 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.4 | 0.9 | GO:0046640 | regulation of alpha-beta T cell proliferation(GO:0046640) |
0.4 | 2.2 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
0.4 | 1.7 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.4 | 1.7 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.4 | 3.4 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.4 | 1.3 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.4 | 4.7 | GO:0055013 | cardiac muscle cell development(GO:0055013) |
0.4 | 0.4 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.4 | 0.4 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.4 | 1.3 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.4 | 2.1 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.4 | 10.9 | GO:0010761 | fibroblast migration(GO:0010761) |
0.4 | 1.7 | GO:1902170 | cellular response to reactive nitrogen species(GO:1902170) |
0.4 | 5.4 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.4 | 1.2 | GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0010880) |
0.4 | 1.2 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.4 | 1.6 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.4 | 1.2 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.4 | 0.8 | GO:0065001 | specification of axis polarity(GO:0065001) |
0.4 | 1.2 | GO:0048207 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.4 | 0.8 | GO:0002432 | granuloma formation(GO:0002432) |
0.4 | 1.2 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.4 | 1.6 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.4 | 2.4 | GO:0045046 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.4 | 1.2 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
0.4 | 1.2 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.4 | 8.0 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.4 | 0.8 | GO:0001780 | neutrophil homeostasis(GO:0001780) |
0.4 | 0.4 | GO:0071635 | negative regulation of transforming growth factor beta production(GO:0071635) |
0.4 | 2.0 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.4 | 0.8 | GO:0010887 | negative regulation of cholesterol storage(GO:0010887) |
0.4 | 0.4 | GO:0043368 | positive T cell selection(GO:0043368) |
0.4 | 1.6 | GO:0019532 | oxalate transport(GO:0019532) |
0.4 | 0.4 | GO:0006113 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.4 | 1.2 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.4 | 3.2 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.4 | 0.4 | GO:0033762 | response to glucagon(GO:0033762) |
0.4 | 6.0 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.4 | 1.2 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.4 | 0.8 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.4 | 0.8 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.4 | 3.1 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.4 | 1.2 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.4 | 1.2 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
0.4 | 1.2 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.4 | 0.4 | GO:0002337 | B-1 B cell differentiation(GO:0001923) B-1a B cell differentiation(GO:0002337) |
0.4 | 2.7 | GO:0046473 | phosphatidic acid metabolic process(GO:0046473) |
0.4 | 2.7 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.4 | 1.5 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.4 | 1.5 | GO:0051639 | actin filament network formation(GO:0051639) |
0.4 | 1.2 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) negative regulation of dendritic cell differentiation(GO:2001199) |
0.4 | 0.4 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.4 | 1.5 | GO:0032308 | positive regulation of prostaglandin secretion(GO:0032308) |
0.4 | 0.8 | GO:0002360 | T cell lineage commitment(GO:0002360) |
0.4 | 4.2 | GO:0016556 | mRNA modification(GO:0016556) |
0.4 | 3.0 | GO:0046688 | response to copper ion(GO:0046688) |
0.4 | 0.4 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.4 | 2.6 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.4 | 0.8 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.4 | 0.4 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.4 | 0.8 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
0.4 | 1.1 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
0.4 | 0.4 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.4 | 1.5 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.4 | 0.4 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.4 | 0.4 | GO:0045852 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
0.4 | 1.5 | GO:0046689 | response to mercury ion(GO:0046689) |
0.4 | 1.9 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.4 | 4.1 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.4 | 1.5 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.4 | 1.1 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.4 | 0.7 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.4 | 1.8 | GO:2000121 | regulation of removal of superoxide radicals(GO:2000121) |
0.4 | 2.2 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.4 | 2.2 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.4 | 10.2 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.4 | 1.4 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.4 | 0.7 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.4 | 1.4 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.4 | 0.7 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.4 | 1.8 | GO:0046130 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.4 | 1.1 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.4 | 1.1 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.4 | 0.4 | GO:0048382 | mesendoderm development(GO:0048382) corticotropin hormone secreting cell differentiation(GO:0060128) |
0.4 | 2.1 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.4 | 0.4 | GO:0070343 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
0.4 | 1.4 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.4 | 2.5 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.3 | 1.7 | GO:0009164 | nucleoside catabolic process(GO:0009164) |
0.3 | 1.7 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.3 | 1.0 | GO:0035425 | autocrine signaling(GO:0035425) |
0.3 | 1.0 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.3 | 1.4 | GO:0051697 | protein delipidation(GO:0051697) |
0.3 | 0.3 | GO:0032252 | secretory granule localization(GO:0032252) |
0.3 | 1.0 | GO:0016102 | retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) terpenoid biosynthetic process(GO:0016114) |
0.3 | 2.8 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.3 | 1.0 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.3 | 0.3 | GO:0015889 | cobalamin transport(GO:0015889) |
0.3 | 2.0 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.3 | 1.0 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.3 | 3.7 | GO:0071800 | podosome assembly(GO:0071800) |
0.3 | 0.3 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.3 | 1.3 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.3 | 1.7 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.3 | 1.3 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.3 | 0.7 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.3 | 3.7 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.3 | 1.0 | GO:0009092 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
0.3 | 0.3 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.3 | 2.0 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.3 | 6.3 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.3 | 0.7 | GO:1903797 | positive regulation of inorganic anion transmembrane transport(GO:1903797) |
0.3 | 0.7 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
0.3 | 1.6 | GO:0002349 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.3 | 2.6 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.3 | 3.3 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.3 | 2.3 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.3 | 1.0 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.3 | 1.9 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.3 | 2.3 | GO:0033622 | integrin activation(GO:0033622) |
0.3 | 2.3 | GO:2000778 | positive regulation of interleukin-6 secretion(GO:2000778) |
0.3 | 3.9 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.3 | 0.6 | GO:0061074 | regulation of neural retina development(GO:0061074) |
0.3 | 0.6 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.3 | 0.3 | GO:0032763 | regulation of mast cell cytokine production(GO:0032763) |
0.3 | 1.0 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.3 | 2.2 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
0.3 | 1.6 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.3 | 1.0 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.3 | 1.3 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.3 | 0.6 | GO:0042167 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.3 | 4.8 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.3 | 1.3 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.3 | 0.3 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.3 | 0.3 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.3 | 0.6 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) |
0.3 | 0.3 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.3 | 0.9 | GO:0051775 | response to redox state(GO:0051775) |
0.3 | 0.6 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.3 | 0.6 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.3 | 1.9 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.3 | 0.6 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.3 | 1.3 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.3 | 0.6 | GO:0032960 | regulation of inositol trisphosphate biosynthetic process(GO:0032960) positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
0.3 | 0.3 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.3 | 0.9 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.3 | 1.9 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
0.3 | 0.6 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.3 | 1.6 | GO:0072710 | response to hydroxyurea(GO:0072710) cellular response to hydroxyurea(GO:0072711) |
0.3 | 0.9 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.3 | 0.6 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.3 | 0.3 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.3 | 6.8 | GO:1900077 | negative regulation of cellular response to insulin stimulus(GO:1900077) |
0.3 | 0.3 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.3 | 0.6 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.3 | 0.6 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.3 | 0.9 | GO:0002254 | kinin cascade(GO:0002254) |
0.3 | 0.9 | GO:0003383 | apical constriction(GO:0003383) |
0.3 | 0.3 | GO:0071608 | macrophage inflammatory protein-1 alpha production(GO:0071608) |
0.3 | 0.9 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.3 | 0.9 | GO:0051194 | positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
0.3 | 1.8 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.3 | 0.3 | GO:1903795 | regulation of inorganic anion transmembrane transport(GO:1903795) |
0.3 | 0.9 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.3 | 2.4 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.3 | 4.5 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.3 | 1.2 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.3 | 1.5 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
0.3 | 0.9 | GO:0019086 | late viral transcription(GO:0019086) |
0.3 | 0.3 | GO:1905208 | negative regulation of cardiocyte differentiation(GO:1905208) negative regulation of cardiac muscle cell differentiation(GO:2000726) |
0.3 | 2.1 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.3 | 0.6 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.3 | 0.9 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.3 | 0.9 | GO:0042416 | dopamine biosynthetic process(GO:0042416) |
0.3 | 0.6 | GO:2000834 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
0.3 | 3.5 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
0.3 | 0.6 | GO:1901859 | negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
0.3 | 0.3 | GO:0098543 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.3 | 0.9 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.3 | 0.6 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.3 | 2.3 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.3 | 2.1 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.3 | 0.9 | GO:0070572 | positive regulation of neuron projection regeneration(GO:0070572) |
0.3 | 0.6 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.3 | 0.9 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.3 | 0.9 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.3 | 0.9 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
0.3 | 0.3 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.3 | 0.6 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.3 | 1.2 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
0.3 | 0.6 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.3 | 1.4 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.3 | 1.4 | GO:0034433 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.3 | 1.1 | GO:1904754 | positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
0.3 | 0.3 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.3 | 1.7 | GO:0006907 | pinocytosis(GO:0006907) |
0.3 | 1.4 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.3 | 0.6 | GO:0009080 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
0.3 | 3.4 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.3 | 0.3 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.3 | 0.3 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process from galactose(GO:0061623) |
0.3 | 0.6 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.3 | 0.6 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.3 | 1.1 | GO:1901836 | regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901836) |
0.3 | 1.4 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.3 | 1.4 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.3 | 2.2 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.3 | 0.3 | GO:0042117 | monocyte activation(GO:0042117) |
0.3 | 0.3 | GO:0046719 | regulation by virus of viral protein levels in host cell(GO:0046719) |
0.3 | 1.7 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.3 | 1.4 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.3 | 0.8 | GO:0032782 | bile acid secretion(GO:0032782) |
0.3 | 0.6 | GO:0007567 | parturition(GO:0007567) |
0.3 | 2.5 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.3 | 0.8 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.3 | 0.8 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.3 | 0.8 | GO:0045404 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.3 | 0.8 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.3 | 0.5 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.3 | 0.3 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.3 | 1.1 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.3 | 0.3 | GO:0015705 | iodide transport(GO:0015705) |
0.3 | 0.5 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.3 | 0.8 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.3 | 0.8 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.3 | 0.5 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.3 | 0.8 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.3 | 2.1 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.3 | 1.9 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.3 | 0.8 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.3 | 0.5 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.3 | 1.1 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.3 | 1.9 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
0.3 | 1.1 | GO:0010955 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
0.3 | 1.8 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.3 | 0.3 | GO:0036120 | response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.3 | 0.3 | GO:0046137 | negative regulation of vitamin metabolic process(GO:0046137) |
0.3 | 0.3 | GO:0042525 | tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
0.3 | 0.3 | GO:0043650 | dicarboxylic acid biosynthetic process(GO:0043650) |
0.3 | 6.2 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.3 | 0.3 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.3 | 0.5 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.3 | 1.3 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.3 | 0.5 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.3 | 4.1 | GO:0030195 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.3 | 2.3 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.3 | 1.3 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.3 | 1.0 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.3 | 0.3 | GO:0003256 | regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003256) positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003257) |
0.3 | 1.0 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.3 | 0.8 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.3 | 0.8 | GO:0030920 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.3 | 0.3 | GO:0002638 | negative regulation of immunoglobulin production(GO:0002638) |
0.3 | 0.3 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
0.3 | 0.3 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
0.3 | 0.8 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.3 | 0.8 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.3 | 0.5 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.3 | 0.5 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.3 | 1.0 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.3 | 0.5 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.3 | 0.5 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.3 | 0.8 | GO:0048102 | autophagic cell death(GO:0048102) |
0.3 | 0.3 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
0.3 | 0.3 | GO:0071888 | macrophage apoptotic process(GO:0071888) regulation of macrophage apoptotic process(GO:2000109) |
0.3 | 0.5 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.3 | 0.8 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.3 | 0.3 | GO:2000909 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
0.3 | 2.0 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.2 | 0.7 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.2 | 2.2 | GO:0030038 | contractile actin filament bundle assembly(GO:0030038) stress fiber assembly(GO:0043149) |
0.2 | 1.2 | GO:0002070 | epithelial cell maturation(GO:0002070) |
0.2 | 0.7 | GO:0000467 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
0.2 | 2.2 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.2 | 0.5 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.2 | 0.2 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.2 | 0.7 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.2 | 0.7 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.2 | 0.7 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.2 | 0.7 | GO:0070488 | neutrophil aggregation(GO:0070488) |
0.2 | 0.2 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
0.2 | 0.7 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.2 | 4.1 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.2 | 0.2 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.2 | 2.4 | GO:0032620 | interleukin-17 production(GO:0032620) |
0.2 | 0.5 | GO:0061055 | myotome development(GO:0061055) |
0.2 | 2.9 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.2 | 0.2 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
0.2 | 1.2 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
0.2 | 2.4 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.2 | 0.7 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.2 | 0.2 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.2 | 1.4 | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) |
0.2 | 0.2 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.2 | 0.5 | GO:0039535 | regulation of RIG-I signaling pathway(GO:0039535) |
0.2 | 0.7 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.2 | 0.2 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.2 | 0.2 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.2 | 1.9 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.2 | 0.9 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.2 | 0.9 | GO:1904751 | regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
0.2 | 0.5 | GO:0010700 | negative regulation of norepinephrine secretion(GO:0010700) |
0.2 | 0.7 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.2 | 1.4 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.2 | 1.9 | GO:0048535 | lymph node development(GO:0048535) |
0.2 | 0.5 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.2 | 0.5 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
0.2 | 1.2 | GO:0018342 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.2 | 0.2 | GO:0002677 | negative regulation of chronic inflammatory response(GO:0002677) |
0.2 | 0.2 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.2 | 1.4 | GO:0002287 | alpha-beta T cell activation involved in immune response(GO:0002287) |
0.2 | 0.7 | GO:2000973 | pro-B cell differentiation(GO:0002328) regulation of pro-B cell differentiation(GO:2000973) |
0.2 | 0.5 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.2 | 0.5 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.2 | 2.7 | GO:0015858 | nucleoside transport(GO:0015858) |
0.2 | 3.0 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.2 | 0.5 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.2 | 0.2 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.2 | 0.5 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.2 | 1.8 | GO:0002347 | response to tumor cell(GO:0002347) |
0.2 | 0.7 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.2 | 0.9 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.2 | 0.2 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.2 | 1.3 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.2 | 0.4 | GO:0006848 | pyruvate transport(GO:0006848) |
0.2 | 4.9 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.2 | 0.4 | GO:0070842 | aggresome assembly(GO:0070842) |
0.2 | 4.5 | GO:0009813 | flavonoid biosynthetic process(GO:0009813) flavonoid glucuronidation(GO:0052696) |
0.2 | 1.1 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.2 | 0.2 | GO:0003180 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
0.2 | 1.3 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
0.2 | 0.7 | GO:0018343 | protein farnesylation(GO:0018343) |
0.2 | 0.2 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.2 | 0.4 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
0.2 | 0.7 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
0.2 | 0.9 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.2 | 0.2 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.2 | 0.2 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.2 | 4.8 | GO:0055092 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
0.2 | 0.7 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.2 | 2.8 | GO:0033198 | response to ATP(GO:0033198) |
0.2 | 0.2 | GO:1901535 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
0.2 | 0.9 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.2 | 0.2 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.2 | 0.9 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.2 | 0.6 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.2 | 0.6 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.2 | 0.6 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.2 | 0.2 | GO:0031943 | regulation of glucocorticoid metabolic process(GO:0031943) |
0.2 | 0.6 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.2 | 0.8 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.2 | 0.2 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
0.2 | 2.5 | GO:0033006 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
0.2 | 0.6 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.2 | 0.6 | GO:0086004 | regulation of cardiac muscle cell contraction(GO:0086004) |
0.2 | 0.2 | GO:0061356 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.2 | 0.2 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
0.2 | 0.2 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.2 | 0.2 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.2 | 0.8 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.2 | 4.5 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.2 | 2.2 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.2 | 0.2 | GO:2000810 | regulation of bicellular tight junction assembly(GO:2000810) |
0.2 | 0.6 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.2 | 3.2 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.2 | 1.0 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.2 | 0.8 | GO:0010635 | regulation of mitochondrial fusion(GO:0010635) |
0.2 | 0.6 | GO:0001916 | positive regulation of T cell mediated cytotoxicity(GO:0001916) |
0.2 | 1.6 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.2 | 3.2 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.2 | 0.8 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.2 | 0.4 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.2 | 0.2 | GO:0001562 | response to protozoan(GO:0001562) |
0.2 | 1.0 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.2 | 0.2 | GO:0002431 | Fc receptor mediated stimulatory signaling pathway(GO:0002431) |
0.2 | 0.4 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.2 | 1.6 | GO:1902400 | signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) |
0.2 | 1.0 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.2 | 0.6 | GO:0002934 | desmosome organization(GO:0002934) |
0.2 | 1.6 | GO:0043471 | regulation of carbohydrate catabolic process(GO:0043470) regulation of cellular carbohydrate catabolic process(GO:0043471) |
0.2 | 0.2 | GO:0035973 | aggrephagy(GO:0035973) |
0.2 | 0.4 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.2 | 0.2 | GO:1901674 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
0.2 | 0.4 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.2 | 0.2 | GO:0016553 | base conversion or substitution editing(GO:0016553) |
0.2 | 1.6 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.2 | 1.6 | GO:0016446 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.2 | 1.4 | GO:0006108 | malate metabolic process(GO:0006108) |
0.2 | 1.7 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.2 | 0.8 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.2 | 2.7 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.2 | 1.2 | GO:0014823 | response to activity(GO:0014823) |
0.2 | 0.6 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.2 | 0.2 | GO:0032070 | regulation of deoxyribonuclease activity(GO:0032070) |
0.2 | 1.5 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.2 | 0.2 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.2 | 0.4 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.2 | 0.6 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.2 | 0.2 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.2 | 0.2 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) |
0.2 | 0.2 | GO:0051181 | cofactor transport(GO:0051181) |
0.2 | 0.4 | GO:0072672 | neutrophil extravasation(GO:0072672) |
0.2 | 1.1 | GO:0032324 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.2 | 0.2 | GO:0019048 | modulation by virus of host morphology or physiology(GO:0019048) |
0.2 | 0.4 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
0.2 | 0.4 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.2 | 0.2 | GO:1901077 | relaxation of cardiac muscle(GO:0055119) regulation of relaxation of muscle(GO:1901077) |
0.2 | 0.7 | GO:0000237 | leptotene(GO:0000237) |
0.2 | 0.2 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.2 | 0.4 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.2 | 0.4 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
0.2 | 1.1 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.2 | 0.9 | GO:1904970 | brush border assembly(GO:1904970) |
0.2 | 0.2 | GO:0002884 | negative regulation of hypersensitivity(GO:0002884) |
0.2 | 0.9 | GO:0003299 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.2 | 0.4 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.2 | 1.6 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.2 | 0.5 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.2 | 1.2 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.2 | 1.1 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.2 | 0.4 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.2 | 1.0 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.2 | 0.3 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.2 | 0.5 | GO:0010863 | positive regulation of phospholipase C activity(GO:0010863) |
0.2 | 0.7 | GO:0006942 | regulation of striated muscle contraction(GO:0006942) |
0.2 | 0.9 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.2 | 1.2 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.2 | 0.2 | GO:0002604 | dendritic cell antigen processing and presentation(GO:0002468) regulation of dendritic cell antigen processing and presentation(GO:0002604) |
0.2 | 0.3 | GO:0048478 | replication fork protection(GO:0048478) |
0.2 | 0.2 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.2 | 1.4 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.2 | 1.2 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.2 | 0.3 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.2 | 1.2 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.2 | 2.4 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.2 | 0.2 | GO:0042345 | regulation of NF-kappaB import into nucleus(GO:0042345) NF-kappaB import into nucleus(GO:0042348) |
0.2 | 0.7 | GO:0051031 | tRNA transport(GO:0051031) |
0.2 | 0.8 | GO:1901658 | glycosyl compound catabolic process(GO:1901658) |
0.2 | 0.8 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.2 | 0.2 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.2 | 0.3 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.2 | 0.5 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.2 | 1.8 | GO:0009225 | nucleotide-sugar metabolic process(GO:0009225) |
0.2 | 1.5 | GO:0051383 | kinetochore organization(GO:0051383) |
0.2 | 0.8 | GO:0016266 | O-glycan processing(GO:0016266) |
0.2 | 0.8 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.2 | 1.8 | GO:0006739 | NADP metabolic process(GO:0006739) |
0.2 | 0.2 | GO:0052203 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.2 | 0.2 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.2 | 0.7 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.2 | 0.3 | GO:0042374 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.2 | 2.0 | GO:0006465 | signal peptide processing(GO:0006465) |
0.2 | 1.8 | GO:0043297 | apical junction assembly(GO:0043297) |
0.2 | 0.5 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.2 | 0.2 | GO:0001927 | exocyst assembly(GO:0001927) |
0.2 | 0.6 | GO:0014829 | vascular smooth muscle contraction(GO:0014829) |
0.2 | 0.5 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.2 | 0.2 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.2 | 1.3 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
0.2 | 1.6 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.2 | 0.3 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.2 | 1.0 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.2 | 2.4 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.2 | 0.5 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.2 | 0.2 | GO:1903298 | regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) |
0.2 | 0.3 | GO:0002215 | defense response to nematode(GO:0002215) |
0.2 | 0.5 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.2 | 0.3 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
0.2 | 0.2 | GO:0048340 | paraxial mesoderm morphogenesis(GO:0048340) paraxial mesoderm formation(GO:0048341) |
0.2 | 0.3 | GO:0006086 | acetyl-CoA biosynthetic process from pyruvate(GO:0006086) |
0.2 | 0.6 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.2 | 0.6 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.2 | 0.2 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.2 | 0.5 | GO:0030859 | polarized epithelial cell differentiation(GO:0030859) |
0.2 | 0.3 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
0.2 | 0.6 | GO:1902583 | intracellular transport of virus(GO:0075733) multi-organism intracellular transport(GO:1902583) |
0.2 | 0.5 | GO:0070344 | fat cell proliferation(GO:0070341) regulation of fat cell proliferation(GO:0070344) |
0.2 | 1.1 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.2 | 0.2 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.2 | 0.5 | GO:0034310 | primary alcohol catabolic process(GO:0034310) |
0.2 | 0.2 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
0.2 | 0.2 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
0.2 | 0.2 | GO:0060982 | coronary artery morphogenesis(GO:0060982) |
0.2 | 0.2 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
0.2 | 0.2 | GO:1904180 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.2 | 0.9 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.2 | 0.8 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.2 | 0.2 | GO:0009624 | response to nematode(GO:0009624) |
0.2 | 2.6 | GO:0043616 | keratinocyte proliferation(GO:0043616) |
0.2 | 0.5 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.2 | 0.9 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.2 | 0.3 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.2 | 0.3 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.2 | 0.2 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.2 | 0.3 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.1 | 2.8 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.1 | 0.4 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.1 | 0.3 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
0.1 | 1.0 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.1 | 1.2 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.1 | 0.7 | GO:1900118 | negative regulation of execution phase of apoptosis(GO:1900118) |
0.1 | 2.5 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.1 | 0.4 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.1 | 0.1 | GO:1903818 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.1 | 0.7 | GO:0071549 | cellular response to dexamethasone stimulus(GO:0071549) |
0.1 | 4.1 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.1 | 0.1 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.1 | 0.3 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) galactolipid metabolic process(GO:0019374) |
0.1 | 0.1 | GO:0010165 | response to X-ray(GO:0010165) |
0.1 | 0.4 | GO:0033700 | phospholipid efflux(GO:0033700) |
0.1 | 1.3 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.1 | 0.7 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.1 | 0.4 | GO:1902913 | positive regulation of neuroepithelial cell differentiation(GO:1902913) |
0.1 | 0.4 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.1 | 0.6 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.1 | 0.1 | GO:0002517 | T cell tolerance induction(GO:0002517) |
0.1 | 4.6 | GO:0002286 | T cell activation involved in immune response(GO:0002286) |
0.1 | 0.3 | GO:1903053 | regulation of extracellular matrix organization(GO:1903053) |
0.1 | 0.4 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.1 | 2.4 | GO:0030593 | neutrophil chemotaxis(GO:0030593) |
0.1 | 0.1 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.1 | 0.1 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.1 | 1.0 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.1 | 0.3 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.1 | 0.1 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.1 | 0.3 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
0.1 | 0.3 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.1 | 1.3 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.1 | 0.6 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.1 | 0.1 | GO:0045416 | positive regulation of interleukin-8 biosynthetic process(GO:0045416) |
0.1 | 0.7 | GO:0031670 | cellular response to nutrient(GO:0031670) |
0.1 | 0.3 | GO:0007296 | vitellogenesis(GO:0007296) |
0.1 | 0.1 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
0.1 | 0.4 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.1 | 0.4 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.1 | 1.7 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
0.1 | 0.7 | GO:0097341 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.1 | 2.8 | GO:0048146 | positive regulation of fibroblast proliferation(GO:0048146) |
0.1 | 0.4 | GO:0010755 | regulation of plasminogen activation(GO:0010755) positive regulation of plasminogen activation(GO:0010756) |
0.1 | 1.0 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.1 | 1.6 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.1 | 0.7 | GO:0019400 | alditol metabolic process(GO:0019400) |
0.1 | 0.3 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.1 | 0.1 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
0.1 | 0.4 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.1 | 0.1 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.1 | 0.1 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.1 | 1.6 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.1 | 0.5 | GO:0032964 | collagen biosynthetic process(GO:0032964) |
0.1 | 0.9 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.1 | 0.1 | GO:0046078 | dUMP metabolic process(GO:0046078) |
0.1 | 0.1 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
0.1 | 0.8 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) |
0.1 | 0.5 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.1 | 0.4 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.1 | 1.2 | GO:0042537 | benzene-containing compound metabolic process(GO:0042537) |
0.1 | 0.1 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.1 | 0.3 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.1 | 1.5 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.1 | 0.4 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.1 | 3.7 | GO:0009060 | aerobic respiration(GO:0009060) |
0.1 | 0.7 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.1 | 0.3 | GO:0044144 | regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
0.1 | 0.7 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 0.1 | GO:0007144 | female meiosis I(GO:0007144) |
0.1 | 0.5 | GO:0030049 | muscle filament sliding(GO:0030049) |
0.1 | 0.4 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.1 | 0.6 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.1 | 0.5 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.1 | 0.8 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.1 | 0.4 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.1 | 1.7 | GO:0006953 | acute-phase response(GO:0006953) |
0.1 | 0.4 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.1 | 0.3 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.1 | 0.1 | GO:0051665 | membrane raft localization(GO:0051665) |
0.1 | 0.8 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.1 | 0.6 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.1 | 0.1 | GO:0048069 | eye pigmentation(GO:0048069) |
0.1 | 0.1 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.1 | 0.4 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.1 | 0.2 | GO:0006531 | aspartate metabolic process(GO:0006531) aspartate biosynthetic process(GO:0006532) |
0.1 | 0.2 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
0.1 | 0.5 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.1 | 0.4 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
0.1 | 0.2 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.1 | 0.4 | GO:0009109 | coenzyme catabolic process(GO:0009109) |
0.1 | 0.2 | GO:0016093 | polyprenol metabolic process(GO:0016093) |
0.1 | 2.2 | GO:0071479 | cellular response to ionizing radiation(GO:0071479) |
0.1 | 0.1 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.1 | 0.1 | GO:2001169 | regulation of ATP biosynthetic process(GO:2001169) |
0.1 | 0.1 | GO:0002767 | immune response-inhibiting signal transduction(GO:0002765) immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.1 | 0.5 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 1.1 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.1 | 0.5 | GO:0018317 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.1 | 0.4 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.1 | 0.4 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.1 | 1.1 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.1 | 1.0 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.1 | 0.8 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
0.1 | 0.5 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.1 | 0.4 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.1 | 0.4 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.1 | 1.6 | GO:0048661 | positive regulation of smooth muscle cell proliferation(GO:0048661) |
0.1 | 1.1 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.1 | 0.2 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
0.1 | 0.1 | GO:0061724 | lipophagy(GO:0061724) |
0.1 | 1.1 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.1 | 1.2 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.1 | 0.5 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.1 | 0.4 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.1 | 0.1 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.1 | 0.4 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.1 | 0.4 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.1 | 0.4 | GO:0051000 | positive regulation of nitric-oxide synthase activity(GO:0051000) |
0.1 | 0.6 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.1 | 0.6 | GO:0070168 | negative regulation of biomineral tissue development(GO:0070168) |
0.1 | 0.5 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.1 | 0.1 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.1 | 0.1 | GO:0010958 | regulation of amino acid import(GO:0010958) |
0.1 | 0.6 | GO:0018101 | protein citrullination(GO:0018101) |
0.1 | 0.6 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.1 | 0.5 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.1 | 0.2 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.1 | 1.0 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
0.1 | 0.5 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.1 | 0.7 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.1 | 2.0 | GO:0046825 | regulation of protein export from nucleus(GO:0046825) |
0.1 | 0.3 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 0.8 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.1 | 0.9 | GO:0050892 | intestinal absorption(GO:0050892) |
0.1 | 1.0 | GO:0002224 | toll-like receptor signaling pathway(GO:0002224) |
0.1 | 0.1 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
0.1 | 0.2 | GO:0030242 | pexophagy(GO:0030242) |
0.1 | 0.1 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.1 | 0.2 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.1 | 0.1 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.1 | 0.1 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.1 | 0.3 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.1 | 0.3 | GO:0016559 | peroxisome fission(GO:0016559) |
0.1 | 0.3 | GO:0002584 | negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
0.1 | 0.1 | GO:0006598 | polyamine catabolic process(GO:0006598) |
0.1 | 0.2 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.1 | 0.2 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.1 | 0.5 | GO:0009249 | protein lipoylation(GO:0009249) |
0.1 | 1.2 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.1 | 0.1 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.1 | 0.2 | GO:0050942 | positive regulation of developmental pigmentation(GO:0048087) positive regulation of pigment cell differentiation(GO:0050942) |
0.1 | 1.2 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.1 | 1.6 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.1 | 0.2 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.1 | 0.2 | GO:0044788 | modulation by host of viral process(GO:0044788) |
0.1 | 0.3 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.1 | 0.7 | GO:0055021 | regulation of cardiac muscle tissue growth(GO:0055021) |
0.1 | 0.1 | GO:0044783 | G1 DNA damage checkpoint(GO:0044783) |
0.1 | 0.3 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.1 | 0.4 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.1 | 0.4 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
0.1 | 0.3 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.1 | 0.1 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.1 | 0.2 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.1 | 0.2 | GO:1901798 | positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.1 | 0.6 | GO:0009086 | methionine biosynthetic process(GO:0009086) |
0.1 | 0.4 | GO:0006548 | histidine catabolic process(GO:0006548) imidazole-containing compound metabolic process(GO:0052803) imidazole-containing compound catabolic process(GO:0052805) |
0.1 | 0.2 | GO:0033227 | dsRNA transport(GO:0033227) |
0.1 | 0.1 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.1 | 0.2 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.1 | 0.3 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.1 | 0.4 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.1 | 0.3 | GO:0044038 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.1 | 0.6 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.1 | 0.2 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.1 | 0.4 | GO:1902254 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902254) |
0.1 | 1.1 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
0.1 | 0.8 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.1 | 0.9 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.1 | 0.4 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.1 | 0.5 | GO:0035812 | renal sodium excretion(GO:0035812) regulation of renal sodium excretion(GO:0035813) |
0.1 | 2.0 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
0.1 | 0.5 | GO:0034204 | lipid translocation(GO:0034204) |
0.1 | 1.3 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
0.1 | 0.1 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
0.1 | 0.1 | GO:1903975 | regulation of glial cell migration(GO:1903975) |
0.1 | 0.7 | GO:0002504 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
0.1 | 0.3 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.1 | 0.6 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
0.1 | 0.3 | GO:0035822 | meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
0.1 | 0.4 | GO:0098763 | mitotic cell cycle phase(GO:0098763) |
0.1 | 1.1 | GO:0045576 | mast cell activation(GO:0045576) |
0.1 | 0.3 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.1 | 1.2 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.1 | 0.1 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.1 | 0.1 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
0.1 | 0.4 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.1 | 0.2 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.1 | 8.9 | GO:0051607 | defense response to virus(GO:0051607) |
0.1 | 0.6 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.1 | 0.5 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) |
0.1 | 0.5 | GO:0060736 | prostate gland growth(GO:0060736) |
0.1 | 0.1 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.1 | 0.5 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.1 | 0.1 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.1 | 0.3 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.1 | 0.1 | GO:0032674 | regulation of interleukin-5 production(GO:0032674) |
0.1 | 0.5 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.1 | 0.5 | GO:0000096 | sulfur amino acid metabolic process(GO:0000096) |
0.1 | 0.2 | GO:0032823 | regulation of natural killer cell differentiation(GO:0032823) |
0.1 | 0.9 | GO:0070232 | regulation of T cell apoptotic process(GO:0070232) |
0.1 | 0.6 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.1 | 0.1 | GO:0019240 | citrulline biosynthetic process(GO:0019240) |
0.1 | 0.6 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.1 | 1.1 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.1 | 0.4 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.1 | 1.2 | GO:0044264 | cellular polysaccharide metabolic process(GO:0044264) |
0.1 | 0.1 | GO:2000637 | positive regulation of gene silencing by miRNA(GO:2000637) |
0.1 | 0.1 | GO:0090148 | membrane fission(GO:0090148) |
0.1 | 4.9 | GO:0007599 | hemostasis(GO:0007599) |
0.1 | 1.2 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.1 | 3.2 | GO:0007030 | Golgi organization(GO:0007030) |
0.1 | 0.4 | GO:0051084 | 'de novo' protein folding(GO:0006458) 'de novo' posttranslational protein folding(GO:0051084) |
0.1 | 0.1 | GO:0032667 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) |
0.1 | 0.6 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.1 | 0.1 | GO:0031049 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.1 | 0.3 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.1 | 1.0 | GO:0051601 | exocyst localization(GO:0051601) |
0.1 | 1.1 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.1 | 0.1 | GO:0042891 | antibiotic transport(GO:0042891) |
0.1 | 0.4 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
0.1 | 0.2 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.1 | 0.1 | GO:0072718 | response to cisplatin(GO:0072718) |
0.1 | 0.2 | GO:0098787 | mRNA cleavage involved in mRNA processing(GO:0098787) |
0.1 | 0.2 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.1 | 1.6 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.1 | 0.1 | GO:0018410 | C-terminal protein amino acid modification(GO:0018410) |
0.1 | 0.9 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.1 | 0.1 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.1 | 0.8 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.1 | 0.7 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.1 | 1.3 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.1 | 0.6 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.1 | 0.6 | GO:0006757 | ATP generation from ADP(GO:0006757) |
0.1 | 5.8 | GO:0007266 | Rho protein signal transduction(GO:0007266) |
0.1 | 0.2 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.1 | 0.1 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.1 | 0.2 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.1 | 0.1 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.1 | 0.3 | GO:1901978 | positive regulation of cell cycle checkpoint(GO:1901978) |
0.1 | 0.1 | GO:0009301 | snRNA transcription(GO:0009301) |
0.1 | 0.3 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.1 | 0.7 | GO:0042026 | protein refolding(GO:0042026) |
0.1 | 0.2 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 0.5 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.1 | 0.3 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.1 | 0.5 | GO:0009081 | branched-chain amino acid metabolic process(GO:0009081) |
0.1 | 0.3 | GO:0071692 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.1 | 0.1 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.1 | 0.2 | GO:0046909 | intermembrane transport(GO:0046909) |
0.1 | 0.1 | GO:0032757 | positive regulation of interleukin-8 production(GO:0032757) |
0.1 | 1.4 | GO:0042089 | cytokine biosynthetic process(GO:0042089) |
0.1 | 0.1 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.1 | 0.1 | GO:0097205 | renal filtration(GO:0097205) |
0.1 | 0.3 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.1 | 0.1 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.1 | 0.1 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.1 | 0.2 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.1 | 0.1 | GO:0032682 | negative regulation of chemokine production(GO:0032682) |
0.1 | 0.4 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
0.1 | 2.1 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.1 | 0.1 | GO:0032594 | protein transport within lipid bilayer(GO:0032594) |
0.1 | 0.4 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.1 | 0.3 | GO:1901534 | positive regulation of megakaryocyte differentiation(GO:0045654) positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.1 | 0.1 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.1 | 0.4 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.1 | 0.2 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.1 | 0.1 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.1 | 0.3 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.1 | 0.2 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.1 | 2.2 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.1 | 0.2 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.1 | 0.4 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.1 | 0.3 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.1 | 0.3 | GO:1904353 | regulation of telomere capping(GO:1904353) positive regulation of telomere capping(GO:1904355) |
0.1 | 0.5 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.1 | 0.3 | GO:0015893 | drug transport(GO:0015893) |
0.1 | 0.2 | GO:0001842 | neural fold formation(GO:0001842) |
0.1 | 0.1 | GO:0051702 | interaction with symbiont(GO:0051702) |
0.1 | 0.1 | GO:0035404 | histone-serine phosphorylation(GO:0035404) |
0.1 | 0.2 | GO:0009067 | aspartate family amino acid biosynthetic process(GO:0009067) |
0.1 | 0.2 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.1 | 0.1 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.1 | 0.1 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.1 | 1.7 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.1 | 0.1 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.1 | 0.1 | GO:0033081 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.1 | 0.2 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.1 | 2.3 | GO:0000724 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.1 | 0.6 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.1 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
0.1 | 0.1 | GO:0045297 | mating plug formation(GO:0042628) post-mating behavior(GO:0045297) |
0.1 | 0.1 | GO:0031663 | lipopolysaccharide-mediated signaling pathway(GO:0031663) |
0.1 | 0.1 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.1 | 0.2 | GO:0090077 | foam cell differentiation(GO:0090077) |
0.1 | 0.4 | GO:0072676 | lymphocyte migration(GO:0072676) |
0.1 | 0.1 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.1 | 0.4 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.1 | 0.1 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.1 | 0.1 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.1 | 0.1 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.1 | 0.1 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.1 | 0.1 | GO:1902713 | regulation of interferon-gamma secretion(GO:1902713) |
0.1 | 0.1 | GO:0044004 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
0.1 | 0.3 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.1 | 0.2 | GO:0090153 | regulation of sphingolipid biosynthetic process(GO:0090153) regulation of membrane lipid metabolic process(GO:1905038) regulation of ceramide biosynthetic process(GO:2000303) |
0.1 | 0.1 | GO:0060760 | positive regulation of response to cytokine stimulus(GO:0060760) |
0.1 | 0.1 | GO:0035112 | genitalia morphogenesis(GO:0035112) |
0.1 | 0.1 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.1 | 0.2 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 0.2 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.1 | 0.5 | GO:0051180 | vitamin transport(GO:0051180) |
0.1 | 0.1 | GO:0072603 | interleukin-5 secretion(GO:0072603) interleukin-13 secretion(GO:0072611) regulation of interleukin-5 secretion(GO:2000662) positive regulation of interleukin-5 secretion(GO:2000664) regulation of interleukin-13 secretion(GO:2000665) positive regulation of interleukin-13 secretion(GO:2000667) |
0.1 | 0.2 | GO:1902591 | single-organism membrane budding(GO:1902591) |
0.1 | 0.2 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.1 | 0.1 | GO:0042107 | cytokine metabolic process(GO:0042107) |
0.1 | 0.1 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.1 | 0.2 | GO:0051231 | mitotic spindle elongation(GO:0000022) spindle elongation(GO:0051231) spindle midzone assembly(GO:0051255) mitotic spindle midzone assembly(GO:0051256) |
0.1 | 0.4 | GO:2001244 | positive regulation of intrinsic apoptotic signaling pathway(GO:2001244) |
0.1 | 1.3 | GO:0048002 | antigen processing and presentation of peptide antigen(GO:0048002) |
0.1 | 0.5 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.0 | 0.1 | GO:0046697 | decidualization(GO:0046697) |
0.0 | 0.3 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.0 | 0.1 | GO:0050854 | regulation of antigen receptor-mediated signaling pathway(GO:0050854) |
0.0 | 0.7 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
0.0 | 0.7 | GO:0030968 | endoplasmic reticulum unfolded protein response(GO:0030968) |
0.0 | 0.5 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.0 | 0.0 | GO:0046633 | alpha-beta T cell proliferation(GO:0046633) |
0.0 | 0.0 | GO:0014717 | regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) |
0.0 | 0.0 | GO:0051204 | protein insertion into mitochondrial membrane(GO:0051204) |
0.0 | 0.4 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.0 | 1.4 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.0 | 0.1 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.0 | 0.8 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.0 | 0.1 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.0 | 0.5 | GO:0006301 | postreplication repair(GO:0006301) |
0.0 | 0.8 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.0 | 0.0 | GO:0042182 | ketone catabolic process(GO:0042182) |
0.0 | 0.1 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.0 | 0.1 | GO:0006983 | ER overload response(GO:0006983) |
0.0 | 0.3 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.2 | GO:0030575 | nuclear body organization(GO:0030575) |
0.0 | 0.6 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.0 | 0.7 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.0 | 0.1 | GO:0090220 | chromosome localization to nuclear envelope involved in homologous chromosome segregation(GO:0090220) |
0.0 | 0.1 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.0 | 0.8 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.0 | 0.1 | GO:0042398 | cellular modified amino acid biosynthetic process(GO:0042398) |
0.0 | 0.2 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.0 | 0.1 | GO:0090071 | regulation of ribosome biogenesis(GO:0090069) negative regulation of ribosome biogenesis(GO:0090071) |
0.0 | 0.4 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.0 | 0.0 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.0 | 0.3 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.0 | 0.0 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.0 | 0.0 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.0 | 0.3 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.0 | 0.7 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.0 | 0.5 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 0.1 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.0 | 0.0 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.0 | 0.1 | GO:0007097 | nuclear migration(GO:0007097) |
0.0 | 0.9 | GO:0042073 | intraciliary transport(GO:0042073) protein transport along microtubule(GO:0098840) |
0.0 | 0.1 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.0 | 0.1 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.0 | 0.1 | GO:0090383 | phagosome acidification(GO:0090383) |
0.0 | 0.3 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.0 | 0.6 | GO:0007569 | cell aging(GO:0007569) |
0.0 | 0.0 | GO:1902235 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
0.0 | 0.3 | GO:0006826 | iron ion transport(GO:0006826) |
0.0 | 0.1 | GO:0042559 | pteridine-containing compound biosynthetic process(GO:0042559) |
0.0 | 0.2 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.0 | 0.3 | GO:0050715 | positive regulation of cytokine secretion(GO:0050715) |
0.0 | 0.2 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.0 | 0.1 | GO:1903301 | positive regulation of hexokinase activity(GO:1903301) |
0.0 | 0.2 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.0 | 0.4 | GO:0016180 | snRNA processing(GO:0016180) |
0.0 | 0.1 | GO:0032689 | negative regulation of interferon-gamma production(GO:0032689) |
0.0 | 2.2 | GO:0042742 | defense response to bacterium(GO:0042742) |
0.0 | 0.0 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
0.0 | 0.9 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.0 | 0.1 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.0 | 0.1 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.0 | 0.0 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.0 | 0.1 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.0 | 0.1 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.0 | 0.1 | GO:0007141 | male meiosis I(GO:0007141) |
0.0 | 0.0 | GO:0046459 | short-chain fatty acid metabolic process(GO:0046459) |
0.0 | 0.8 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.0 | 0.0 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) |
0.0 | 0.0 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.0 | 0.2 | GO:0036093 | germ cell proliferation(GO:0036093) |
0.0 | 0.0 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.0 | 0.1 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.0 | 0.0 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.0 | 0.0 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.0 | 0.0 | GO:0019730 | antimicrobial humoral response(GO:0019730) |
0.0 | 0.0 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.0 | 0.1 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
0.0 | 0.0 | GO:0030421 | defecation(GO:0030421) |
0.0 | 0.4 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.0 | 0.2 | GO:0035690 | cellular response to drug(GO:0035690) |
0.0 | 0.0 | GO:0060049 | regulation of protein glycosylation(GO:0060049) |
0.0 | 0.0 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.0 | 0.0 | GO:0031343 | positive regulation of cell killing(GO:0031343) |
0.0 | 0.2 | GO:1902571 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.0 | 0.2 | GO:0009615 | response to virus(GO:0009615) |
0.0 | 0.0 | GO:0045779 | negative regulation of bone resorption(GO:0045779) |
0.0 | 0.0 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.0 | 0.0 | GO:0006778 | porphyrin-containing compound metabolic process(GO:0006778) |
0.0 | 0.1 | GO:0019363 | pyridine nucleotide biosynthetic process(GO:0019363) |
0.0 | 0.2 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
0.0 | 0.0 | GO:1902895 | positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
0.0 | 0.1 | GO:0072337 | modified amino acid transport(GO:0072337) |
0.0 | 0.0 | GO:0048070 | regulation of developmental pigmentation(GO:0048070) |
0.0 | 0.0 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.0 | 0.2 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.0 | 0.0 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.0 | 0.1 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.0 | 0.0 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.0 | 0.0 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.0 | 0.1 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.0 | 0.0 | GO:0005976 | polysaccharide metabolic process(GO:0005976) |
0.0 | 0.0 | GO:0002763 | positive regulation of myeloid leukocyte differentiation(GO:0002763) |
0.0 | 0.0 | GO:0051014 | actin filament severing(GO:0051014) |
0.0 | 0.0 | GO:2000508 | regulation of dendritic cell chemotaxis(GO:2000508) |
0.0 | 0.0 | GO:0006568 | tryptophan metabolic process(GO:0006568) indolalkylamine metabolic process(GO:0006586) |
0.0 | 0.1 | GO:0071320 | cellular response to cAMP(GO:0071320) |
0.0 | 0.0 | GO:0019585 | uronic acid metabolic process(GO:0006063) glucuronate metabolic process(GO:0019585) cellular glucuronidation(GO:0052695) |
0.0 | 0.2 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.0 | 0.1 | GO:0048525 | negative regulation of viral process(GO:0048525) |
0.0 | 0.0 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.0 | 0.0 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.0 | 0.1 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.0 | 0.0 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
0.0 | 0.0 | GO:0055006 | cardiac cell development(GO:0055006) |
0.0 | 0.1 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.0 | 0.0 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.0 | 0.0 | GO:0060416 | response to growth hormone(GO:0060416) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.3 | 10.0 | GO:0097512 | cardiac myofibril(GO:0097512) |
3.2 | 9.6 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
3.1 | 27.5 | GO:0005859 | muscle myosin complex(GO:0005859) |
2.4 | 7.1 | GO:0032127 | dense core granule membrane(GO:0032127) |
2.0 | 6.1 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
2.0 | 15.9 | GO:0005861 | troponin complex(GO:0005861) |
2.0 | 23.9 | GO:0031430 | M band(GO:0031430) |
1.6 | 9.5 | GO:0031983 | vesicle lumen(GO:0031983) |
1.5 | 7.7 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
1.4 | 4.2 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
1.4 | 5.5 | GO:0030478 | actin cap(GO:0030478) |
1.3 | 3.8 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
1.2 | 14.0 | GO:0005916 | fascia adherens(GO:0005916) |
1.2 | 5.8 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
1.2 | 3.5 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
1.1 | 5.4 | GO:0016461 | unconventional myosin complex(GO:0016461) |
1.0 | 3.1 | GO:0005899 | insulin receptor complex(GO:0005899) |
1.0 | 4.1 | GO:0071438 | invadopodium membrane(GO:0071438) |
1.0 | 1.0 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
1.0 | 7.9 | GO:0030314 | junctional membrane complex(GO:0030314) |
1.0 | 13.8 | GO:0005865 | striated muscle thin filament(GO:0005865) |
1.0 | 5.8 | GO:0097342 | ripoptosome(GO:0097342) |
1.0 | 2.9 | GO:1990357 | terminal web(GO:1990357) |
1.0 | 10.5 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.9 | 5.3 | GO:0030056 | hemidesmosome(GO:0030056) |
0.9 | 2.6 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.9 | 2.6 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.8 | 5.0 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.8 | 3.3 | GO:0071953 | elastic fiber(GO:0071953) |
0.8 | 11.3 | GO:0043034 | costamere(GO:0043034) |
0.8 | 2.4 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.8 | 12.6 | GO:0031672 | A band(GO:0031672) |
0.8 | 4.7 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.8 | 4.7 | GO:0098645 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.8 | 6.2 | GO:0020003 | symbiont-containing vacuole(GO:0020003) |
0.7 | 2.9 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.7 | 6.4 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.7 | 41.4 | GO:0042641 | actomyosin(GO:0042641) |
0.7 | 2.1 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.7 | 2.8 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.7 | 11.6 | GO:0005614 | interstitial matrix(GO:0005614) |
0.7 | 2.0 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.6 | 3.8 | GO:0005915 | zonula adherens(GO:0005915) |
0.6 | 1.2 | GO:0005914 | spot adherens junction(GO:0005914) |
0.6 | 2.4 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.6 | 0.6 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.6 | 1.2 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.6 | 2.4 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.6 | 5.2 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.6 | 5.6 | GO:0002102 | podosome(GO:0002102) |
0.6 | 7.2 | GO:0098644 | complex of collagen trimers(GO:0098644) |
0.6 | 1.7 | GO:0097443 | sorting endosome(GO:0097443) |
0.5 | 1.6 | GO:0048179 | activin receptor complex(GO:0048179) |
0.5 | 2.2 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.5 | 2.7 | GO:0045180 | basal cortex(GO:0045180) |
0.5 | 3.2 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.5 | 2.6 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.5 | 3.1 | GO:0042629 | mast cell granule(GO:0042629) |
0.5 | 3.1 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.5 | 3.6 | GO:0090543 | Flemming body(GO:0090543) |
0.5 | 13.9 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.5 | 43.7 | GO:0030016 | myofibril(GO:0030016) |
0.5 | 3.5 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.5 | 1.5 | GO:0031523 | Myb complex(GO:0031523) |
0.5 | 1.5 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.5 | 9.5 | GO:0014704 | intercalated disc(GO:0014704) |
0.5 | 0.9 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.5 | 1.4 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.5 | 2.3 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.5 | 9.9 | GO:0008305 | integrin complex(GO:0008305) |
0.4 | 3.1 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.4 | 0.9 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.4 | 1.3 | GO:0044462 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.4 | 1.3 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.4 | 2.6 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.4 | 4.6 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.4 | 29.7 | GO:0005604 | basement membrane(GO:0005604) |
0.4 | 2.0 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.4 | 5.6 | GO:0030315 | T-tubule(GO:0030315) |
0.4 | 1.6 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.4 | 4.3 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.4 | 12.5 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.4 | 3.1 | GO:0042587 | glycogen granule(GO:0042587) |
0.4 | 3.5 | GO:0001527 | microfibril(GO:0001527) |
0.4 | 1.6 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.4 | 0.8 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.4 | 1.1 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.4 | 19.9 | GO:0042383 | sarcolemma(GO:0042383) |
0.4 | 2.2 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.4 | 1.1 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.4 | 1.8 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.4 | 0.7 | GO:0097413 | Lewy body(GO:0097413) |
0.4 | 0.7 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.4 | 0.7 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.4 | 3.9 | GO:0042581 | specific granule(GO:0042581) |
0.3 | 3.1 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.3 | 1.4 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.3 | 1.0 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.3 | 1.3 | GO:0018995 | host(GO:0018995) host cell part(GO:0033643) host cell(GO:0043657) |
0.3 | 1.0 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.3 | 1.6 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.3 | 2.9 | GO:0097542 | ciliary tip(GO:0097542) |
0.3 | 1.3 | GO:1990130 | Iml1 complex(GO:1990130) |
0.3 | 5.0 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.3 | 9.7 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.3 | 0.3 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.3 | 7.1 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.3 | 6.2 | GO:0001772 | immunological synapse(GO:0001772) |
0.3 | 1.2 | GO:0035363 | histone locus body(GO:0035363) |
0.3 | 0.3 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.3 | 1.2 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.3 | 17.4 | GO:0005811 | lipid particle(GO:0005811) |
0.3 | 2.3 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.3 | 4.1 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.3 | 0.3 | GO:1990393 | 3M complex(GO:1990393) |
0.3 | 1.7 | GO:0042588 | zymogen granule(GO:0042588) |
0.3 | 3.4 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.3 | 2.5 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.3 | 1.1 | GO:0070876 | SOSS complex(GO:0070876) |
0.3 | 2.5 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.3 | 61.7 | GO:0005925 | focal adhesion(GO:0005925) |
0.3 | 2.5 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.3 | 0.3 | GO:0043219 | lateral loop(GO:0043219) |
0.3 | 21.3 | GO:0072562 | blood microparticle(GO:0072562) |
0.3 | 1.6 | GO:0042627 | chylomicron(GO:0042627) |
0.3 | 1.1 | GO:1990246 | uniplex complex(GO:1990246) |
0.3 | 1.6 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.3 | 3.4 | GO:0043218 | compact myelin(GO:0043218) |
0.3 | 2.6 | GO:0031528 | microvillus membrane(GO:0031528) |
0.3 | 1.8 | GO:0030681 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.3 | 0.5 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.3 | 0.3 | GO:0016460 | myosin II complex(GO:0016460) |
0.3 | 0.8 | GO:0043296 | apical junction complex(GO:0043296) |
0.3 | 4.3 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.3 | 2.0 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.2 | 6.0 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.2 | 1.5 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.2 | 2.9 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.2 | 0.2 | GO:0000322 | storage vacuole(GO:0000322) |
0.2 | 0.7 | GO:0043293 | apoptosome(GO:0043293) |
0.2 | 1.2 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.2 | 3.4 | GO:0030057 | desmosome(GO:0030057) |
0.2 | 11.1 | GO:0005902 | microvillus(GO:0005902) |
0.2 | 0.2 | GO:0032009 | early phagosome(GO:0032009) |
0.2 | 0.2 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.2 | 0.7 | GO:0071942 | XPC complex(GO:0071942) |
0.2 | 0.5 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.2 | 3.5 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.2 | 0.4 | GO:0000235 | astral microtubule(GO:0000235) |
0.2 | 1.1 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.2 | 1.1 | GO:0097422 | tubular endosome(GO:0097422) |
0.2 | 1.9 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.2 | 0.4 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.2 | 0.9 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.2 | 1.5 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.2 | 1.3 | GO:0031415 | NatA complex(GO:0031415) |
0.2 | 2.3 | GO:0046930 | pore complex(GO:0046930) |
0.2 | 0.2 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.2 | 0.6 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.2 | 0.8 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.2 | 0.6 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.2 | 0.8 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.2 | 1.4 | GO:0036038 | MKS complex(GO:0036038) |
0.2 | 0.6 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.2 | 2.9 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.2 | 1.0 | GO:0005683 | U7 snRNP(GO:0005683) |
0.2 | 1.0 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.2 | 0.8 | GO:0016600 | flotillin complex(GO:0016600) |
0.2 | 0.6 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.2 | 0.6 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.2 | 1.9 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.2 | 0.4 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.2 | 8.2 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.2 | 1.3 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.2 | 0.2 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.2 | 0.6 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.2 | 0.7 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.2 | 1.1 | GO:0070847 | core mediator complex(GO:0070847) |
0.2 | 9.7 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.2 | 0.7 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.2 | 0.9 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.2 | 1.4 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.2 | 0.5 | GO:0098536 | deuterosome(GO:0098536) |
0.2 | 1.2 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.2 | 2.8 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.2 | 1.4 | GO:0070652 | HAUS complex(GO:0070652) |
0.2 | 0.7 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.2 | 2.1 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.2 | 0.9 | GO:0060091 | kinocilium(GO:0060091) |
0.2 | 0.8 | GO:0042382 | paraspeckles(GO:0042382) |
0.2 | 0.5 | GO:0043511 | inhibin complex(GO:0043511) |
0.2 | 0.5 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.2 | 0.8 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.2 | 0.3 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.2 | 0.5 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.2 | 0.2 | GO:0044449 | contractile fiber part(GO:0044449) |
0.2 | 0.2 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.2 | 0.3 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.2 | 0.5 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.2 | 12.5 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.2 | 2.5 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.2 | 2.3 | GO:0044438 | microbody part(GO:0044438) peroxisomal part(GO:0044439) |
0.2 | 12.1 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.2 | 0.5 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.2 | 2.1 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.1 | 0.4 | GO:0005712 | chiasma(GO:0005712) |
0.1 | 0.1 | GO:0000779 | condensed chromosome, centromeric region(GO:0000779) |
0.1 | 2.0 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 1.0 | GO:0070187 | telosome(GO:0070187) |
0.1 | 0.9 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 1.4 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.1 | 0.5 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.1 | 0.7 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 0.3 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.1 | 4.6 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.1 | 0.4 | GO:1990423 | RZZ complex(GO:1990423) |
0.1 | 2.3 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 0.3 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.1 | 3.3 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.1 | 0.8 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.1 | 0.1 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.1 | 0.5 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.1 | 1.5 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 9.6 | GO:0005938 | cell cortex(GO:0005938) |
0.1 | 0.2 | GO:0070069 | cytochrome complex(GO:0070069) |
0.1 | 3.6 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 1.1 | GO:0097526 | U4/U6 x U5 tri-snRNP complex(GO:0046540) spliceosomal tri-snRNP complex(GO:0097526) |
0.1 | 0.9 | GO:0032797 | SMN complex(GO:0032797) |
0.1 | 0.6 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.1 | 0.7 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 4.1 | GO:0005901 | caveola(GO:0005901) |
0.1 | 0.7 | GO:0000796 | condensin complex(GO:0000796) |
0.1 | 10.9 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.1 | 1.2 | GO:0016580 | Sin3 complex(GO:0016580) |
0.1 | 0.2 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.1 | 3.9 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.1 | 0.3 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.1 | 0.7 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.1 | 0.9 | GO:0000922 | spindle pole(GO:0000922) |
0.1 | 0.6 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.1 | 0.4 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.1 | 1.5 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 0.4 | GO:0000812 | Swr1 complex(GO:0000812) |
0.1 | 0.7 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.1 | 0.5 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.1 | 0.8 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 0.3 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 0.3 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.1 | 2.6 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.1 | 0.5 | GO:0000805 | X chromosome(GO:0000805) |
0.1 | 6.4 | GO:0016605 | PML body(GO:0016605) |
0.1 | 0.1 | GO:0035061 | interchromatin granule(GO:0035061) |
0.1 | 0.2 | GO:0072687 | meiotic spindle(GO:0072687) |
0.1 | 21.8 | GO:0031012 | extracellular matrix(GO:0031012) |
0.1 | 0.4 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.1 | 0.5 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.1 | 0.8 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.1 | 0.3 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.1 | 0.2 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.1 | 24.5 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.1 | 2.0 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.1 | 0.2 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.1 | 0.2 | GO:0001652 | granular component(GO:0001652) |
0.1 | 0.4 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) lumenal side of membrane(GO:0098576) |
0.1 | 0.3 | GO:0072487 | MSL complex(GO:0072487) |
0.1 | 0.6 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 0.3 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.1 | 5.8 | GO:0000776 | kinetochore(GO:0000776) |
0.1 | 0.3 | GO:0001650 | fibrillar center(GO:0001650) |
0.1 | 0.8 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.1 | 5.2 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 1.2 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.1 | 0.2 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.1 | 0.6 | GO:0001520 | outer dense fiber(GO:0001520) |
0.1 | 0.2 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.1 | 0.5 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 0.9 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.1 | 14.3 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 0.4 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.1 | 0.2 | GO:1990923 | PET complex(GO:1990923) |
0.1 | 0.6 | GO:0036157 | outer dynein arm(GO:0036157) |
0.1 | 0.4 | GO:0031261 | DNA replication preinitiation complex(GO:0031261) |
0.1 | 0.1 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.1 | 0.4 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.1 | 19.7 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.1 | 0.2 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.1 | 0.7 | GO:0005795 | Golgi stack(GO:0005795) |
0.1 | 0.1 | GO:0002177 | manchette(GO:0002177) |
0.1 | 0.2 | GO:0016589 | NURF complex(GO:0016589) |
0.1 | 0.1 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 0.2 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.1 | 1.6 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.1 | 0.6 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.1 | 2.1 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.1 | 0.2 | GO:0030990 | intraciliary transport particle(GO:0030990) |
0.1 | 0.3 | GO:0045298 | tubulin complex(GO:0045298) |
0.1 | 0.1 | GO:0036452 | ESCRT complex(GO:0036452) |
0.1 | 3.7 | GO:0000793 | condensed chromosome(GO:0000793) |
0.1 | 0.5 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 0.3 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.1 | 0.3 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.1 | 0.1 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.1 | 0.2 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 0.9 | GO:0034451 | centriolar satellite(GO:0034451) |
0.1 | 3.4 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.1 | 0.4 | GO:0071546 | pi-body(GO:0071546) |
0.1 | 0.5 | GO:0000124 | SAGA complex(GO:0000124) |
0.1 | 87.1 | GO:0070062 | extracellular exosome(GO:0070062) |
0.1 | 5.5 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.1 | 1.5 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.1 | 0.5 | GO:0097546 | ciliary base(GO:0097546) |
0.1 | 0.1 | GO:0005818 | aster(GO:0005818) |
0.1 | 0.6 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.1 | 0.6 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 0.1 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.1 | 2.0 | GO:0005643 | nuclear pore(GO:0005643) |
0.1 | 0.4 | GO:0005685 | U1 snRNP(GO:0005685) |
0.1 | 1.2 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.1 | 0.3 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.1 | 0.3 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 0.5 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.0 | 2.0 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.1 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.0 | 0.1 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.0 | 0.1 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.0 | 0.0 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.0 | 9.7 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 12.8 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.0 | 0.4 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.0 | 0.5 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.0 | 0.1 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.0 | 0.0 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.0 | 0.1 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.0 | 0.3 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.0 | 1.1 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.0 | 0.1 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.0 | 0.2 | GO:0001939 | female pronucleus(GO:0001939) |
0.0 | 24.0 | GO:0005739 | mitochondrion(GO:0005739) |
0.0 | 0.1 | GO:1990462 | omegasome(GO:1990462) |
0.0 | 0.1 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.0 | 0.1 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.0 | 1.2 | GO:0031514 | motile cilium(GO:0031514) |
0.0 | 0.1 | GO:0051233 | spindle midzone(GO:0051233) |
0.0 | 0.0 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.0 | 0.9 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.0 | 0.1 | GO:0000346 | transcription export complex(GO:0000346) |
0.0 | 0.0 | GO:0005638 | lamin filament(GO:0005638) |
0.0 | 0.2 | GO:0005771 | multivesicular body(GO:0005771) |
0.0 | 0.6 | GO:0016363 | nuclear matrix(GO:0016363) |
0.0 | 0.1 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.0 | 0.3 | GO:0005657 | replication fork(GO:0005657) |
0.0 | 1.2 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.0 | 0.7 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.0 | 0.2 | GO:0044815 | DNA packaging complex(GO:0044815) |
0.0 | 0.0 | GO:0036128 | CatSper complex(GO:0036128) |
0.0 | 0.0 | GO:0061689 | tricellular tight junction(GO:0061689) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.1 | 24.6 | GO:0031433 | telethonin binding(GO:0031433) |
3.1 | 15.3 | GO:0051525 | NFAT protein binding(GO:0051525) |
2.1 | 6.3 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
1.8 | 5.5 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
1.8 | 5.4 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
1.8 | 7.1 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
1.7 | 5.0 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
1.6 | 4.9 | GO:0030172 | troponin C binding(GO:0030172) |
1.6 | 11.0 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
1.5 | 4.4 | GO:0031013 | troponin I binding(GO:0031013) |
1.4 | 5.7 | GO:0031720 | haptoglobin binding(GO:0031720) |
1.4 | 14.0 | GO:0005523 | tropomyosin binding(GO:0005523) |
1.4 | 12.2 | GO:0031432 | titin binding(GO:0031432) |
1.4 | 5.4 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
1.3 | 9.4 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
1.2 | 4.8 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
1.2 | 3.5 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
1.2 | 7.0 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
1.1 | 1.1 | GO:0051373 | FATZ binding(GO:0051373) |
1.1 | 3.3 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
1.1 | 3.3 | GO:0004064 | arylesterase activity(GO:0004064) |
1.1 | 6.5 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
1.1 | 7.6 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
1.1 | 5.3 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
1.1 | 13.8 | GO:0008307 | structural constituent of muscle(GO:0008307) |
1.0 | 5.2 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
1.0 | 3.0 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
1.0 | 3.0 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
1.0 | 4.0 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
1.0 | 4.9 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
1.0 | 10.8 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
1.0 | 10.5 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.9 | 2.8 | GO:0035939 | microsatellite binding(GO:0035939) |
0.9 | 3.7 | GO:0071253 | connexin binding(GO:0071253) |
0.9 | 2.8 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.9 | 2.8 | GO:0051425 | PTB domain binding(GO:0051425) |
0.9 | 1.8 | GO:0043495 | protein anchor(GO:0043495) |
0.9 | 2.7 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.9 | 5.3 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.9 | 2.6 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.9 | 3.4 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.8 | 0.8 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.8 | 10.0 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.8 | 2.5 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.8 | 2.4 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.8 | 3.2 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.8 | 2.4 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.8 | 4.8 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.8 | 3.9 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.8 | 3.1 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.8 | 3.1 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.8 | 2.3 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.8 | 3.0 | GO:0043515 | kinetochore binding(GO:0043515) |
0.8 | 3.0 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.7 | 0.7 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.7 | 9.6 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.7 | 3.7 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.7 | 7.4 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.7 | 2.2 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.7 | 3.6 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.7 | 5.8 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.7 | 2.2 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.7 | 0.7 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.7 | 5.0 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.7 | 3.6 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.7 | 2.1 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.7 | 2.1 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.7 | 2.8 | GO:0034547 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
0.7 | 4.9 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.7 | 4.2 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.7 | 1.4 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
0.7 | 0.7 | GO:0034618 | arginine binding(GO:0034618) |
0.7 | 5.6 | GO:0017166 | vinculin binding(GO:0017166) |
0.7 | 2.8 | GO:0019158 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.7 | 2.8 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.7 | 2.1 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.7 | 2.1 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.7 | 2.0 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.7 | 8.7 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.7 | 2.0 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.7 | 4.0 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.7 | 4.7 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.7 | 1.3 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
0.6 | 1.9 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.6 | 2.6 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.6 | 1.9 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.6 | 1.9 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.6 | 1.9 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.6 | 1.9 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.6 | 3.1 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.6 | 3.1 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.6 | 6.2 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.6 | 9.9 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.6 | 9.9 | GO:0030506 | ankyrin binding(GO:0030506) |
0.6 | 1.8 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.6 | 3.7 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.6 | 2.5 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.6 | 1.8 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.6 | 2.4 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.6 | 11.5 | GO:0042805 | actinin binding(GO:0042805) |
0.6 | 2.4 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.6 | 4.2 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.6 | 1.8 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.6 | 7.0 | GO:0001846 | opsonin binding(GO:0001846) |
0.6 | 1.7 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.6 | 2.9 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.6 | 1.1 | GO:0060229 | phospholipase activator activity(GO:0016004) lipase activator activity(GO:0060229) |
0.6 | 1.7 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.6 | 1.7 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.6 | 1.1 | GO:0055100 | adiponectin binding(GO:0055100) |
0.6 | 2.2 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.6 | 3.3 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
0.6 | 2.8 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.6 | 3.3 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.5 | 1.6 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.5 | 5.5 | GO:0044548 | S100 protein binding(GO:0044548) |
0.5 | 4.4 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.5 | 1.1 | GO:0048030 | disaccharide binding(GO:0048030) |
0.5 | 2.1 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.5 | 1.6 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.5 | 2.6 | GO:0052724 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.5 | 4.2 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.5 | 5.7 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.5 | 5.2 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.5 | 2.1 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.5 | 1.5 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.5 | 3.1 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.5 | 0.5 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.5 | 1.5 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.5 | 1.0 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.5 | 4.0 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.5 | 1.5 | GO:0035877 | death effector domain binding(GO:0035877) |
0.5 | 1.5 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.5 | 2.5 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.5 | 1.0 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.5 | 1.5 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.5 | 3.0 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.5 | 1.5 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.5 | 2.4 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.5 | 1.5 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.5 | 0.5 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
0.5 | 1.9 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.5 | 3.4 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.5 | 1.0 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.5 | 2.4 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.5 | 9.6 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.5 | 4.3 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.5 | 1.4 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.5 | 1.4 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.5 | 1.4 | GO:0008515 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.5 | 1.4 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.5 | 13.2 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.5 | 1.4 | GO:0030984 | kininogen binding(GO:0030984) |
0.5 | 1.4 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.5 | 1.4 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.5 | 1.4 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.5 | 2.7 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.5 | 0.5 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.5 | 4.5 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.5 | 3.2 | GO:0005536 | glucose binding(GO:0005536) |
0.4 | 1.3 | GO:2001070 | starch binding(GO:2001070) |
0.4 | 2.2 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.4 | 1.8 | GO:0009374 | biotin binding(GO:0009374) |
0.4 | 0.9 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.4 | 4.0 | GO:0005123 | death receptor binding(GO:0005123) |
0.4 | 0.4 | GO:0031014 | troponin T binding(GO:0031014) |
0.4 | 0.4 | GO:1901682 | sulfur compound transmembrane transporter activity(GO:1901682) |
0.4 | 1.3 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.4 | 1.3 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.4 | 4.7 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.4 | 3.0 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.4 | 1.3 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.4 | 1.7 | GO:0018812 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) |
0.4 | 1.3 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.4 | 1.3 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.4 | 1.3 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.4 | 0.8 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.4 | 5.4 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.4 | 1.7 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.4 | 2.0 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.4 | 1.2 | GO:0019862 | IgA binding(GO:0019862) |
0.4 | 1.2 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.4 | 0.4 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
0.4 | 2.4 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.4 | 1.2 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.4 | 1.6 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.4 | 1.2 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.4 | 1.2 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.4 | 1.2 | GO:0030911 | TPR domain binding(GO:0030911) |
0.4 | 7.4 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.4 | 1.2 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.4 | 4.7 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.4 | 0.8 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.4 | 1.5 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.4 | 1.5 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.4 | 6.8 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.4 | 0.7 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.4 | 1.5 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.4 | 1.5 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.4 | 1.1 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.4 | 0.7 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.4 | 2.6 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.4 | 5.1 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.4 | 1.8 | GO:0043426 | MRF binding(GO:0043426) |
0.4 | 1.4 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.4 | 5.4 | GO:0030552 | cAMP binding(GO:0030552) |
0.4 | 1.1 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.4 | 1.1 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.4 | 2.8 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.4 | 18.4 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.4 | 5.3 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.4 | 1.4 | GO:0070513 | death domain binding(GO:0070513) |
0.4 | 0.4 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
0.4 | 1.8 | GO:0030553 | cGMP binding(GO:0030553) |
0.4 | 23.9 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.3 | 1.0 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.3 | 0.3 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.3 | 12.3 | GO:0005088 | Ras guanyl-nucleotide exchange factor activity(GO:0005088) |
0.3 | 1.0 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.3 | 0.7 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.3 | 0.7 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.3 | 1.0 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.3 | 1.0 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.3 | 2.0 | GO:0051400 | BH domain binding(GO:0051400) |
0.3 | 2.0 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.3 | 5.6 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.3 | 1.3 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.3 | 1.0 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.3 | 1.0 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.3 | 1.6 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.3 | 1.0 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.3 | 1.6 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.3 | 1.3 | GO:0019808 | polyamine binding(GO:0019808) |
0.3 | 1.0 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.3 | 1.3 | GO:0030274 | LIM domain binding(GO:0030274) |
0.3 | 3.5 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.3 | 0.6 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.3 | 0.9 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.3 | 0.9 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.3 | 2.2 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.3 | 1.6 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.3 | 1.9 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.3 | 1.6 | GO:0015922 | aspartate oxidase activity(GO:0015922) |
0.3 | 0.9 | GO:0019956 | chemokine binding(GO:0019956) |
0.3 | 1.2 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.3 | 5.5 | GO:0003785 | actin monomer binding(GO:0003785) |
0.3 | 1.5 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.3 | 6.4 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.3 | 2.7 | GO:0001848 | complement binding(GO:0001848) |
0.3 | 1.8 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.3 | 0.3 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.3 | 0.3 | GO:1904680 | peptide-transporting ATPase activity(GO:0015440) peptide transmembrane transporter activity(GO:1904680) |
0.3 | 1.2 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.3 | 1.5 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.3 | 0.9 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.3 | 0.9 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.3 | 2.0 | GO:0102336 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.3 | 0.9 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.3 | 6.9 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.3 | 0.6 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.3 | 3.1 | GO:0043274 | phospholipase binding(GO:0043274) |
0.3 | 1.1 | GO:0060090 | binding, bridging(GO:0060090) |
0.3 | 1.1 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.3 | 1.1 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.3 | 2.5 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.3 | 6.8 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.3 | 0.6 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.3 | 0.3 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.3 | 12.5 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.3 | 1.9 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.3 | 2.2 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.3 | 1.7 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.3 | 2.5 | GO:0034847 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.3 | 0.3 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
0.3 | 4.1 | GO:0016307 | phosphatidylinositol phosphate kinase activity(GO:0016307) |
0.3 | 0.8 | GO:0004359 | glutaminase activity(GO:0004359) |
0.3 | 0.8 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.3 | 1.6 | GO:0015288 | porin activity(GO:0015288) |
0.3 | 0.3 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.3 | 0.8 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.3 | 1.1 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.3 | 1.3 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.3 | 1.6 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.3 | 0.8 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.3 | 1.6 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.3 | 1.1 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.3 | 3.9 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.3 | 3.4 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.3 | 0.8 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.3 | 0.8 | GO:0015232 | heme transporter activity(GO:0015232) |
0.3 | 1.3 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.3 | 1.0 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.3 | 1.8 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.3 | 2.1 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.3 | 1.5 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.3 | 1.8 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.3 | 0.8 | GO:1990190 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.3 | 3.6 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.3 | 1.3 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.3 | 0.8 | GO:0036033 | mediator complex binding(GO:0036033) |
0.3 | 1.0 | GO:0052794 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.3 | 1.3 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.3 | 0.8 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.3 | 0.8 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.3 | 1.3 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
0.3 | 2.0 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.3 | 4.8 | GO:0005537 | mannose binding(GO:0005537) |
0.3 | 1.3 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.3 | 8.3 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.3 | 8.8 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.3 | 1.0 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.2 | 0.7 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.2 | 1.0 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.2 | 2.5 | GO:0001618 | virus receptor activity(GO:0001618) |
0.2 | 0.5 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.2 | 2.0 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.2 | 2.7 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.2 | 1.5 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.2 | 0.7 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.2 | 4.4 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.2 | 1.0 | GO:0033691 | sialic acid binding(GO:0033691) |
0.2 | 2.7 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.2 | 3.2 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.2 | 2.4 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.2 | 0.7 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.2 | 1.0 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.2 | 0.2 | GO:0003896 | DNA primase activity(GO:0003896) |
0.2 | 1.2 | GO:0017040 | ceramidase activity(GO:0017040) |
0.2 | 1.4 | GO:0050700 | CARD domain binding(GO:0050700) |
0.2 | 3.4 | GO:0008143 | poly(A) binding(GO:0008143) |
0.2 | 1.4 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.2 | 0.7 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.2 | 0.5 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.2 | 1.9 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.2 | 4.9 | GO:0043531 | ADP binding(GO:0043531) |
0.2 | 0.7 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.2 | 1.2 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.2 | 0.7 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.2 | 0.7 | GO:0038100 | nodal binding(GO:0038100) |
0.2 | 0.5 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.2 | 7.0 | GO:0005507 | copper ion binding(GO:0005507) |
0.2 | 1.6 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.2 | 3.5 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.2 | 3.4 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.2 | 2.1 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.2 | 0.5 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.2 | 0.5 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.2 | 2.5 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.2 | 2.2 | GO:0035173 | histone kinase activity(GO:0035173) |
0.2 | 0.4 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.2 | 0.9 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.2 | 2.0 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.2 | 0.7 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.2 | 0.9 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.2 | 0.7 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.2 | 2.9 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.2 | 9.5 | GO:0005518 | collagen binding(GO:0005518) |
0.2 | 3.1 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.2 | 0.9 | GO:0019864 | IgG binding(GO:0019864) |
0.2 | 0.9 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.2 | 3.0 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.2 | 4.7 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.2 | 0.2 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.2 | 1.1 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.2 | 1.3 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.2 | 0.4 | GO:0004096 | catalase activity(GO:0004096) |
0.2 | 2.3 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.2 | 2.7 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.2 | 0.8 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.2 | 0.8 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.2 | 0.8 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.2 | 0.2 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.2 | 1.0 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.2 | 1.2 | GO:0045545 | syndecan binding(GO:0045545) |
0.2 | 0.2 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.2 | 0.4 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.2 | 0.4 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.2 | 0.6 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.2 | 1.2 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.2 | 1.0 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.2 | 4.7 | GO:0008748 | N-ethylmaleimide reductase activity(GO:0008748) reduced coenzyme F420 dehydrogenase activity(GO:0043738) sulfur oxygenase reductase activity(GO:0043826) malolactic enzyme activity(GO:0043883) epoxyqueuosine reductase activity(GO:0052693) |
0.2 | 0.6 | GO:0043559 | insulin binding(GO:0043559) |
0.2 | 0.2 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.2 | 0.4 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.2 | 0.4 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.2 | 2.0 | GO:0044466 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.2 | 0.6 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.2 | 1.0 | GO:0039706 | co-receptor binding(GO:0039706) |
0.2 | 0.6 | GO:0015526 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.2 | 2.0 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.2 | 4.3 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.2 | 17.1 | GO:0101005 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.2 | 0.4 | GO:0048185 | activin binding(GO:0048185) |
0.2 | 1.0 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.2 | 0.6 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.2 | 0.2 | GO:0016937 | short-branched-chain-acyl-CoA dehydrogenase activity(GO:0016937) |
0.2 | 1.9 | GO:0005521 | lamin binding(GO:0005521) |
0.2 | 1.5 | GO:0043995 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.2 | 0.4 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.2 | 0.2 | GO:0043398 | HLH domain binding(GO:0043398) |
0.2 | 0.8 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.2 | 0.6 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.2 | 0.4 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.2 | 0.4 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.2 | 47.8 | GO:0003779 | actin binding(GO:0003779) |
0.2 | 0.4 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.2 | 0.4 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.2 | 2.6 | GO:0034594 | phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
0.2 | 0.6 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.2 | 1.8 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.2 | 1.8 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.2 | 0.5 | GO:0097016 | L27 domain binding(GO:0097016) |
0.2 | 0.5 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.2 | 1.3 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.2 | 0.7 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.2 | 0.5 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.2 | 0.4 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.2 | 0.7 | GO:0070728 | leucine binding(GO:0070728) |
0.2 | 0.5 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.2 | 0.7 | GO:0018654 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.2 | 1.0 | GO:0034889 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
0.2 | 0.3 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.2 | 0.7 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.2 | 1.9 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.2 | 2.6 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.2 | 0.2 | GO:0050692 | DBD domain binding(GO:0050692) |
0.2 | 1.2 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.2 | 0.8 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.2 | 0.5 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.2 | 0.7 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.2 | 0.5 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.2 | 2.2 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.2 | 0.2 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.2 | 0.5 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.2 | 0.5 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.2 | 1.2 | GO:0001164 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.2 | 0.5 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.2 | 0.5 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.2 | 0.3 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.2 | 0.7 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.2 | 1.1 | GO:0000150 | recombinase activity(GO:0000150) |
0.2 | 0.3 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.2 | 1.1 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.2 | 1.0 | GO:0034838 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.2 | 0.6 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.2 | 0.6 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.2 | 0.5 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.2 | 3.5 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.2 | 4.1 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.2 | 0.5 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.2 | 0.6 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.2 | 1.3 | GO:0001968 | fibronectin binding(GO:0001968) |
0.2 | 0.3 | GO:0015928 | fucosidase activity(GO:0015928) |
0.2 | 0.5 | GO:0016208 | AMP binding(GO:0016208) |
0.2 | 0.8 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.2 | 0.5 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.2 | 8.4 | GO:0005178 | integrin binding(GO:0005178) |
0.2 | 0.9 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.2 | 0.2 | GO:0002054 | nucleobase binding(GO:0002054) |
0.2 | 4.8 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.2 | 0.2 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.2 | 0.2 | GO:0034711 | inhibin binding(GO:0034711) |
0.2 | 0.3 | GO:0051379 | epinephrine binding(GO:0051379) |
0.2 | 0.5 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.1 | 0.1 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.1 | 0.3 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.1 | 2.5 | GO:0044688 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.1 | 0.3 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.1 | 2.2 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.1 | 0.3 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.1 | 16.1 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 0.6 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.1 | 23.8 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.1 | 0.4 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.1 | 0.3 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.1 | 0.4 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.1 | 0.7 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.1 | 0.4 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.1 | 0.3 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.1 | 0.6 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.1 | 1.4 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.1 | 1.2 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.1 | 1.8 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.1 | 1.8 | GO:0005542 | folic acid binding(GO:0005542) |
0.1 | 0.4 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.1 | 0.7 | GO:0034046 | poly(G) binding(GO:0034046) |
0.1 | 0.7 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.1 | 0.4 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.1 | 0.8 | GO:0035473 | lipase binding(GO:0035473) |
0.1 | 1.7 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.1 | 0.1 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) guanylyltransferase activity(GO:0070568) |
0.1 | 5.8 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.1 | 2.0 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 0.1 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.1 | 0.7 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.1 | 0.5 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.1 | 0.8 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.1 | 0.1 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.1 | 2.4 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.1 | 0.1 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.1 | 1.0 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.1 | 0.1 | GO:0019961 | interferon binding(GO:0019961) |
0.1 | 0.5 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.1 | 0.9 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 0.9 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.1 | 0.4 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.1 | 0.1 | GO:0035276 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) ethanol binding(GO:0035276) |
0.1 | 0.4 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.1 | 0.5 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 1.0 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.1 | 0.1 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.1 | 3.7 | GO:0052770 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.1 | 0.4 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.1 | 0.4 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.1 | 0.2 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.1 | 1.3 | GO:0035870 | dITP diphosphatase activity(GO:0035870) |
0.1 | 0.8 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.1 | 0.7 | GO:0034603 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.1 | 0.6 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.1 | 0.6 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.1 | 0.6 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.1 | 3.8 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.1 | 1.2 | GO:0016405 | CoA-ligase activity(GO:0016405) |
0.1 | 1.4 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.1 | 0.3 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.1 | 0.9 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.1 | 8.8 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.1 | 0.1 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.1 | 0.9 | GO:0031996 | thioesterase binding(GO:0031996) |
0.1 | 0.5 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.1 | 2.1 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 0.3 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.1 | 0.3 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.1 | 0.1 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.1 | 1.7 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.1 | 0.4 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 0.2 | GO:0046915 | transition metal ion transmembrane transporter activity(GO:0046915) |
0.1 | 0.4 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.1 | 0.3 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.1 | 0.1 | GO:0008796 | bis(5'-nucleosyl)-tetraphosphatase activity(GO:0008796) |
0.1 | 0.3 | GO:0016936 | galactoside binding(GO:0016936) |
0.1 | 0.1 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.1 | 0.1 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.1 | 0.1 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.1 | 0.4 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.1 | 0.4 | GO:0035671 | enone reductase activity(GO:0035671) |
0.1 | 4.6 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.1 | 0.8 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 0.5 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.1 | 0.9 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.1 | 0.2 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.1 | 0.3 | GO:0008142 | oxysterol binding(GO:0008142) |
0.1 | 0.4 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 0.1 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.1 | 0.7 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.1 | 1.2 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 2.0 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.1 | 1.9 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 0.1 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 0.2 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) |
0.1 | 0.9 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.1 | 0.8 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 0.3 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.1 | 0.1 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.1 | 0.3 | GO:0015925 | galactosidase activity(GO:0015925) |
0.1 | 0.1 | GO:0035586 | purinergic receptor activity(GO:0035586) |
0.1 | 0.1 | GO:0031782 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.1 | 0.2 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.1 | 0.2 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.1 | 1.3 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 0.9 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 0.4 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.1 | 0.3 | GO:0034595 | phosphatidylinositol phosphate 5-phosphatase activity(GO:0034595) |
0.1 | 0.7 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.1 | 0.7 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 0.3 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.1 | 0.2 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.1 | 1.2 | GO:0004601 | peroxidase activity(GO:0004601) |
0.1 | 0.1 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.1 | 0.4 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 0.4 | GO:0035197 | siRNA binding(GO:0035197) |
0.1 | 0.2 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.1 | 0.1 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.1 | 1.0 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 0.7 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 0.1 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 0.1 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.1 | 2.7 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.1 | 0.3 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.1 | 0.1 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.1 | 0.2 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.1 | 0.1 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.1 | 0.2 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.1 | 0.3 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.1 | 0.3 | GO:0052832 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.1 | 0.8 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.1 | 0.2 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.1 | 0.1 | GO:0050693 | LBD domain binding(GO:0050693) |
0.1 | 6.8 | GO:0005125 | cytokine activity(GO:0005125) |
0.1 | 1.5 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 0.5 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 0.7 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.1 | 1.6 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.1 | 0.1 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 0.2 | GO:0008430 | selenium binding(GO:0008430) |
0.1 | 2.5 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.1 | 0.2 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.1 | 2.7 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.1 | 0.7 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.1 | 1.3 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.1 | 10.2 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.1 | 0.2 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.1 | 0.1 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.1 | 0.7 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.1 | 0.2 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.1 | 0.1 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.1 | 2.7 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.1 | 10.0 | GO:0005525 | GTP binding(GO:0005525) |
0.1 | 2.7 | GO:0019903 | protein phosphatase binding(GO:0019903) |
0.1 | 0.5 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.1 | 0.1 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.1 | 4.7 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 0.1 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.1 | 1.5 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.1 | 0.2 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.1 | 0.7 | GO:0004521 | endoribonuclease activity(GO:0004521) |
0.1 | 0.3 | GO:0019955 | cytokine binding(GO:0019955) |
0.1 | 0.3 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.1 | 0.9 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.1 | 0.5 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.1 | 0.2 | GO:0016725 | oxidoreductase activity, acting on CH or CH2 groups(GO:0016725) |
0.0 | 2.1 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 1.5 | GO:0043765 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.0 | 0.1 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.0 | 0.4 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.0 | 0.1 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.0 | 0.2 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.1 | GO:0000339 | RNA cap binding(GO:0000339) |
0.0 | 0.0 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
0.0 | 0.4 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
0.0 | 0.2 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.0 | 0.4 | GO:0071949 | FAD binding(GO:0071949) |
0.0 | 0.2 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.0 | 0.8 | GO:0016903 | oxidoreductase activity, acting on the aldehyde or oxo group of donors(GO:0016903) |
0.0 | 0.1 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.0 | 0.3 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 0.0 | GO:0008579 | JUN kinase phosphatase activity(GO:0008579) |
0.0 | 0.3 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 0.4 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.0 | 1.5 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 0.6 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.0 | 0.0 | GO:0016289 | CoA hydrolase activity(GO:0016289) |
0.0 | 1.1 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.1 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
0.0 | 0.9 | GO:0000049 | tRNA binding(GO:0000049) |
0.0 | 0.0 | GO:0032190 | acrosin binding(GO:0032190) |
0.0 | 0.2 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.0 | 0.1 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.0 | 0.2 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.0 | 0.1 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.0 | 0.1 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.0 | 0.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.1 | GO:0061659 | ubiquitin-like protein ligase activity(GO:0061659) |
0.0 | 0.1 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.0 | 0.8 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.0 | 0.1 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.0 | 0.1 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.0 | 0.0 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.0 | 0.3 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 1.6 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 0.1 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.0 | 1.0 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.0 | 0.1 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.0 | 0.1 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.0 | 0.2 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 0.1 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.0 | 0.1 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.0 | 0.1 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.0 | 0.2 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.0 | 0.1 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.0 | 0.2 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.0 | 0.1 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.0 | 0.6 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.0 | 0.2 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.0 | 0.2 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.0 | 0.1 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.0 | 0.2 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 0.2 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.0 | 0.0 | GO:0015927 | trehalase activity(GO:0015927) |
0.0 | 0.1 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.0 | 0.2 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.0 | 0.1 | GO:0004953 | icosanoid receptor activity(GO:0004953) |
0.0 | 0.8 | GO:0016875 | ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.0 | 0.1 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.0 | 0.3 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.0 | 0.4 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.0 | 0.0 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.0 | 0.1 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.0 | 0.1 | GO:0015266 | protein channel activity(GO:0015266) |
0.0 | 0.0 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.0 | 0.5 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.0 | 0.8 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.0 | 0.0 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.0 | 0.0 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.0 | 0.2 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.0 | 0.2 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.0 | 0.2 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.0 | 0.1 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.0 | 0.1 | GO:0016160 | amylase activity(GO:0016160) |
0.0 | 0.0 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.0 | 0.0 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.0 | 0.1 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.0 | 0.0 | GO:0000182 | rDNA binding(GO:0000182) |
0.0 | 0.0 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.0 | 0.0 | GO:0015645 | fatty acid ligase activity(GO:0015645) |
0.0 | 0.2 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.0 | 1.1 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.0 | 0.0 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.0 | 0.2 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.0 | 0.0 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.0 | 3.6 | GO:0005198 | structural molecule activity(GO:0005198) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.1 | 2.1 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
1.3 | 1.3 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.9 | 1.8 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.9 | 19.6 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.8 | 23.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.8 | 1.6 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.8 | 1.5 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.7 | 11.6 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.7 | 26.6 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.7 | 4.0 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.7 | 27.4 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.6 | 32.1 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.6 | 30.0 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.6 | 27.3 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.6 | 8.1 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.6 | 22.5 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.6 | 14.6 | PID INSULIN PATHWAY | Insulin Pathway |
0.6 | 3.9 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.6 | 19.4 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.6 | 2.8 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.6 | 15.0 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.5 | 8.8 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.5 | 26.0 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.5 | 13.8 | PID RAS PATHWAY | Regulation of Ras family activation |
0.5 | 3.0 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.5 | 15.0 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.5 | 5.5 | PID EPO PATHWAY | EPO signaling pathway |
0.5 | 7.3 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.5 | 9.7 | PID IFNG PATHWAY | IFN-gamma pathway |
0.5 | 1.4 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.5 | 11.0 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.5 | 2.3 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.5 | 8.9 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.5 | 19.2 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.5 | 14.1 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.5 | 0.5 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.4 | 11.9 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.4 | 14.9 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.4 | 1.3 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.4 | 6.5 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.4 | 9.0 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.4 | 0.4 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.4 | 1.3 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.4 | 4.6 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.4 | 4.6 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.4 | 3.3 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.4 | 16.4 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.4 | 3.3 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.4 | 3.4 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.4 | 2.6 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.4 | 3.5 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.3 | 9.8 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.3 | 5.7 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.3 | 3.6 | PID ALK1 PATHWAY | ALK1 signaling events |
0.3 | 6.5 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.3 | 1.9 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.3 | 2.9 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.3 | 0.9 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.3 | 7.4 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.3 | 2.8 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.3 | 1.2 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.3 | 5.8 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.3 | 6.0 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.3 | 1.4 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.3 | 1.4 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.3 | 2.8 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.3 | 1.1 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.3 | 1.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.3 | 2.9 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.3 | 18.1 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.3 | 1.1 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.3 | 0.5 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.3 | 1.8 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.3 | 7.6 | PID PLK1 PATHWAY | PLK1 signaling events |
0.3 | 1.0 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.3 | 1.3 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.3 | 6.3 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.2 | 5.5 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.2 | 0.7 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.2 | 0.2 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.2 | 1.4 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.2 | 1.7 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.2 | 1.7 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.2 | 2.4 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.2 | 2.3 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.2 | 1.6 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.2 | 2.2 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.2 | 0.6 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.2 | 1.1 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.2 | 0.6 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.2 | 2.5 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.2 | 1.8 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.2 | 0.8 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.2 | 1.0 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.2 | 1.1 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.2 | 0.4 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.2 | 5.8 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.2 | 0.2 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.2 | 3.3 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.2 | 0.5 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.2 | 0.3 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.2 | 0.5 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.2 | 3.7 | PID P73PATHWAY | p73 transcription factor network |
0.2 | 2.0 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.2 | 1.4 | PID ATM PATHWAY | ATM pathway |
0.2 | 0.6 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.2 | 0.5 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.2 | 1.2 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 0.1 | ST ADRENERGIC | Adrenergic Pathway |
0.1 | 27.0 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 3.1 | PID AURORA B PATHWAY | Aurora B signaling |
0.1 | 0.1 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.1 | 1.1 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 1.5 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 1.9 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 2.3 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 1.9 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 1.5 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 0.7 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 0.5 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 1.5 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 1.1 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.1 | 10.5 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 0.3 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.1 | 0.1 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.1 | 0.9 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 0.1 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.1 | 0.3 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 0.1 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 0.8 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 0.1 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.1 | 0.2 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 8.0 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 2.2 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 1.4 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.0 | 1.6 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.0 | 0.2 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.1 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 0.4 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.0 | 0.1 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.0 | 0.1 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 0.6 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 0.1 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 0.5 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 0.1 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.0 | 0.2 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 0.3 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.1 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 0.3 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 0.0 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 0.0 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 0.1 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 0.1 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 0.2 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.0 | 0.0 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 37.6 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
1.1 | 1.1 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
1.0 | 19.5 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.9 | 11.6 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.8 | 8.4 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.8 | 7.9 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.8 | 6.2 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.8 | 8.4 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.7 | 8.1 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.7 | 2.2 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.7 | 1.4 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.7 | 9.7 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.7 | 5.3 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.7 | 8.6 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.7 | 3.9 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.6 | 5.8 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.6 | 31.1 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.6 | 7.0 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.6 | 5.7 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.6 | 16.4 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.6 | 1.9 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.6 | 5.6 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.6 | 3.7 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.6 | 7.4 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.6 | 9.9 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.6 | 5.9 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.6 | 7.0 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.6 | 5.8 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.6 | 10.1 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.6 | 3.9 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.6 | 6.1 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.5 | 4.4 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.5 | 19.2 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.5 | 3.3 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.5 | 6.0 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.5 | 0.5 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.5 | 11.1 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.5 | 10.4 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.5 | 2.6 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.5 | 4.6 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.5 | 7.0 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.5 | 1.5 | REACTOME SIGNALING BY ERBB4 | Genes involved in Signaling by ERBB4 |
0.5 | 5.4 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.5 | 6.3 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.5 | 1.9 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.5 | 3.8 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.5 | 39.1 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.5 | 7.1 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.5 | 3.8 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.5 | 6.5 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.5 | 0.9 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.5 | 4.6 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.5 | 5.5 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.5 | 9.5 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.5 | 0.9 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.5 | 0.5 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.4 | 0.4 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.4 | 41.0 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.4 | 2.6 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.4 | 0.4 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.4 | 9.5 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.4 | 1.3 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.4 | 1.7 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.4 | 10.7 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.4 | 9.9 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.4 | 2.9 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.4 | 3.2 | REACTOME OPSINS | Genes involved in Opsins |
0.4 | 7.3 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.4 | 0.8 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.4 | 3.8 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.4 | 3.0 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.4 | 5.8 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.4 | 1.5 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.4 | 1.4 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.3 | 3.4 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.3 | 3.4 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.3 | 0.3 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.3 | 2.7 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.3 | 3.0 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.3 | 5.6 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.3 | 4.5 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.3 | 5.4 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.3 | 3.5 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.3 | 2.9 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.3 | 4.1 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.3 | 4.4 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.3 | 1.8 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.3 | 3.3 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.3 | 1.2 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.3 | 0.9 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.3 | 6.0 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.3 | 1.8 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.3 | 3.2 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.3 | 7.3 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.3 | 2.9 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.3 | 2.9 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.3 | 18.7 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.3 | 0.3 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.3 | 3.1 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.3 | 3.4 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.3 | 14.5 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.3 | 5.3 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.3 | 1.4 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.3 | 7.5 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.3 | 1.6 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.3 | 0.3 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.3 | 1.9 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.3 | 7.9 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.3 | 0.5 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.3 | 1.3 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.3 | 5.9 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.3 | 16.3 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.2 | 3.6 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.2 | 1.7 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.2 | 1.7 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.2 | 3.5 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.2 | 1.4 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.2 | 2.7 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.2 | 2.5 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.2 | 4.0 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.2 | 0.4 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.2 | 1.9 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.2 | 2.8 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.2 | 1.1 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.2 | 4.0 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.2 | 0.4 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.2 | 4.3 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.2 | 3.5 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.2 | 1.2 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.2 | 2.1 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.2 | 2.8 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.2 | 6.1 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.2 | 5.7 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.2 | 2.6 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.2 | 2.9 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.2 | 2.7 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.2 | 1.1 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.2 | 0.9 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.2 | 0.7 | REACTOME SIGNALING BY WNT | Genes involved in Signaling by Wnt |
0.2 | 1.5 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.2 | 0.8 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.2 | 1.6 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.2 | 1.8 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.2 | 1.1 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.1 | 2.2 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 2.6 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.1 | 8.8 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.1 | 2.1 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.1 | 0.4 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.1 | 0.8 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.1 | 0.1 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.1 | 1.1 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.1 | 5.5 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 1.3 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.1 | 2.6 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 0.5 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.1 | 5.5 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 0.2 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.1 | 2.2 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.1 | 4.5 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 2.5 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.1 | 3.2 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.1 | 0.6 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 0.3 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.1 | 0.6 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.1 | 3.7 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 1.7 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.1 | 0.5 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.1 | 1.2 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.1 | 1.5 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 0.4 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.1 | 0.2 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.1 | 2.8 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.1 | 0.4 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.1 | 1.4 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.1 | 2.1 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 1.4 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.1 | 2.1 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.1 | 0.9 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.1 | 0.2 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.1 | 2.1 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 0.4 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.1 | 0.8 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 0.8 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.1 | 0.5 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 0.3 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.1 | 0.1 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 0.2 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.1 | 3.1 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.1 | 0.8 | REACTOME METABOLISM OF NUCLEOTIDES | Genes involved in Metabolism of nucleotides |
0.1 | 0.4 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
0.1 | 1.6 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 0.2 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 0.1 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.1 | 2.8 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.1 | 1.2 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.1 | 0.2 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 0.6 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 1.5 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 1.0 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.1 | 0.7 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.1 | 2.2 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 1.8 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 0.7 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.1 | 0.3 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.1 | 0.2 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.0 | 0.3 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.0 | 0.6 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 0.1 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.0 | 0.1 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.0 | 1.4 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.2 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.0 | 0.4 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.0 | 0.3 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.0 | 0.1 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.0 | 0.3 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.0 | 0.1 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.0 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
0.0 | 0.2 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 2.7 | REACTOME CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION | Genes involved in Class I MHC mediated antigen processing & presentation |
0.0 | 0.1 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.0 | 0.2 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.0 | 0.1 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.0 | 0.1 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 0.1 | REACTOME SIGNALING BY ILS | Genes involved in Signaling by Interleukins |